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ABSTRACT 
TITLE OF STUDY: A double blinded randomized control trial to comparing the  efficacy of 
oral clonidine  premedication with thedexmedetomidine infusion in the perioperative period,  on 
anaesthetic requirements, haemodynamics and recovery from anaesthesia in patients undergoing 
instrumented spinalfusion. 
DEPARTMENT: Anaesthesia 
NAME OF THE CANDIDATE:Dr. HariNarayanaPrabhu.A 
DEGREE AND SUBJECT: M.D.Anaesthesiology 
NAME OF THE GUIDE: Dr.Ramamani M. 
OBJECTIVES: 
To compare the efficacy of oral clonidine  premedication with dexmedetomidine infusion in the 
perioperative period,onanaesthetic requirements, haemodynamics and recovery from anaesthesia 
in patients undergoing  instrumented spinal fusion. 
METHODS: 
Seventyeligible patients undergoing  two or more level of spinal instrumented fusion (thoracic 
and lumbar) under general anaesthesiawere randomly assigned to receive either oral clonidine 
(200 µg ) as premedication  and  a  bolus of 0.9% normal saline 10 min before induction 
followed by an infusion of 0.9% saline in a predetermined volume (GroupA)  during the intra 
operative period or placebo tablet as premedication and injection  of dexmedetomidine(1µg/kg 
bolus) over 10 mins before induction followed by an infusion (0.5 µg/kg/hr) during the 
intraoperative period (Group B) till the skin closure. Standard anaesthesia protocols for 
induction and maintenance was followed for all. The anaesthetic concentration was titrated to 
keep the BIS between40-60. Morphine 0.1 mg/kg and 1 gm of i.vparacetamolwas givenfor 
analgesia. Intra operative hypertensive responses were treated with bolus dose of fentanyl  
(0.5µg/kg) and propofol (0.5 mg/kg). Intra operative hypotension was treated with either 
ephedrine (5mg bolus) or phenylephrine (50 -100µg) bolus. Variables such as heart rate, blood 
pressure, end tidal concentration and  minimum alveolar concentration of isoflurane are  noted 
every 15 min till the end of skin closure. The total dose of propofol  and fentanyl used, time of 
stopping the study drug, time taken for recovery from anaesthesiawere also noted. 
The variables were analyzed using descriptive statistical methods, means, standard deviation and 
frequency.The outcome variables were compared between the two groups using the independent 
2 sample t – test. Discrete variables were analyzed using Chi –square test for significance. All 
statistical analysis was done using SPSS version 16. 
RESULTS: Demographic data like age, sex, weight, duration of surgery were comparable 
between two groups. Both clonidine and dexmedetomidine reduces the endtidal concentration of 
Isoflurane but the dexmedetomidine  reduces more significantly compared to clonidine at 30 
min, at 1 hr and 2 hrs after proning ( p value 0.03,0.001,0.06 respectively). There was no 
significant difference in heart rate between two groups after the study bolus till the end of 
surgery. Systolic and diastolic and mean blood pressure dropped significantly at the time of 
proning and 5 mins after proning in the dexmedetomidine group compared to clonidine group. P 
value at proning -              
(SBP/DBP/MBP- 0.005/0.07/0.02)  P value at 5 min after proning – (SBP/DBP/MBP –
0.008/0.02/0.02) 
CONCLUSION: Both clonidine and dexmedetomidine  reduces the endtidal concentration of 
Isoflurane but the dexmedetomidine  reduces more significantly compared to clonidine during 
surgery.Intraoperative propofoland analgesic requirement was same between both the 
groups.Both drugs are equally effective for controlling heart rate and  for providing the 
controlled hypotension. Recovery time was not delayed in both the groups. 
Hypotension, Hypertensive, Bradycardiaepisodes were comparable in both the groups.  
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INTRODUCTION 
Patients undergoing spine surgery in prone position are susceptible to 
significant haemodynamic changes.(1,2)  Spine surgery presents a number of 
unique challenges to the anaesthesiologist.(3,4) The emphasis remains on the 
provision of good operative conditions by providing haemodynamic 
stability, minimum interference with the neurological monitoring, and good 
pain relief with multimodal analgesic techniques.  These techniques help for 
a rapid high-quality recovery and early assessment of neurological function.   
These spine surgeries are lengthy and associated with significant 
hypertensive response which intern increase the intraoperative blood loss.(5) 
They require larger dose of opioids and higher concentration of anaesthetic 
agents to suppress the hypertensive response which can interfere with neuro 
monitoring. Also these patients are on chronic pain on preoperative opioids, 
NSAID, acetaminophen. So it is very important to provide opioid-sparing or 
opioid-protective anesthesia techniques to avoid iatrogenic increase in the 
intensity of postoperative pain.  Multi modal analgesic techniques are used 
to avoid the opioid induced side effects (respiratory depression, PONV, 
opioid induced hyper-algesia) and for the faster recovery .Combination of 
strong opioids with non-opioid analgesics (for instance, non-steroidalanti-
inflammatory drugs, acetaminophen, ketamine) have become popular in 
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anesthesia.(6) Recently there has been a great interest in use of perioperative 
systemic α 2 agonists to decrease the peri-operative opioid consumption, 
pain intensity, and nausea. There have been various studies on clonidine or 
Dexmedetomidine and its effects on anesthetic requirement, haemodynamics 
and intra operative and post- operative opioid requirement comparing with 
placebo. There was no study comparing the effect of clonidine as 
premedication vs i.v Dexmedetomidine in the intraoperative period, on the 
anaesthetic requirement, haemodynamics and recovery from anesthesia. We 
conducted a randomized clinical trial comparing the oral clonidine 
premedication vs i.v Dexmedetomidine in the pre and  intraoperative  period, 
on the anaesthetic requirement, haemodynamic response to intubation, 
surgical incision and during surgery also the time to recovery from 
anesthesia. Also we compared the adverse events like hypotension, 
bradycardia between the two groups. Also the intraoperative blood loss 
wascompared between the two groups. 
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AIMS AND OBJECTIVES 
Aim of the study 
To compare the effects of oral clonidine as premedication 
Vsdexmedetomidine infusion in the intraoperative period, in patients 
undergoing instrumented spinal fusion.  
Objective of the Study 
1. To compare the effects of oral clonidine premedication 
Vs.i.vdexmedetomidine infusion in the intraoperative period on the 
anesthetic requirement, haemodynamic response to intubation, 
surgical incision and during surgery, also the recovery time from 
anesthesia in patients undergoing spine surgery with instrumented 
fusion.  
2. To compare the intraoperative analgesic requirement between the two 
drugs.  
3. To compare the adverse events like hypotension, hypertension and 
bradycardia between the two groups. 
4.  To compare the blood loss between the two groups. 
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REVIEW OF LITERATURE 
Spine surgery in prone position: 
Patients undergoing spine surgery in prone position are susceptible to 
significant haemodynamicchanges(7). Anaesthetic considerations for spinal 
surgery include airway management, proper positioning to avoid positioning 
related nerve injury, adopting techniques to minimize the  blood loss(8), 
techniques which allow for adequate  intraoperative neurophysiological 
monitoring, rapid recoveryto assess the neurological status and to provide 
adequate post- operative analgesia(9). The emphasis remains on the 
provision of good operative conditions, assessment and preservation of 
neurological function and a rapid high-quality recovery.  
Low blood pressure, or hypotension, occurs when blood pressure during and 
after each heartbeat is much lower than usual. This means the heart, brain, 
and other parts of the body do not get enough blood.(10) Hypotensive 
episodes are common during anaesthesia, and controlled hypotension was 
once even a popular technique for reducing blood loss during surgery. 
However, because of the unpredictability of cerebral and other organ 
damage resulting from hypotension, most modern anaesthesiologists employ 
controlled hypotension very sparingly, or not at all. Conditions related to the 
deregulation of blood pressure (BP), such as orthostatic hypotension, have 
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been shown to be significantly associated with cardiovascular disease 
(Hypertension, Ischaemic heart disease, Cardiomyopathy, etc.). Recently, 
the prone body position has been recognized as a possible postural factor 
leading to BP deregulation. Yasuharu Tabara et al conducted a cross-
sectional study to investigate the BP response to a change in body position 
from supine to prone. The study subjects consisted of 271 middle-aged 
healthy males, randomly selected from the employees of a large 
manufacturing enterprise in Ehime Prefecture, Japan. Brachial blood 
pressure and heart rate were measured in sitting, supine and prone position 
and each difference was defined as a postural change (11). The postural 
changes in aortic hemodynamics were also assessed using a SphygmoCor 
system. The baseline  BP measured in the sitting position was significantly 
decreased in the supine position (132 18 to 130 17 mmHg, p<0.001). A 
further reduction was observed after the postural change from supine to 
prone (130 17 to 125 16 mmHg, p<0.001). The heart rate was increased 
with the supine-to-prone postural change (4.1 5.8 beats/min, p<0.001), 
while it showed a significant decrease with the sitting-to-supine postural 
change (-7.6 5.6 beats/min, p<0.05). The impact of BP reduction was more 
prominent in the aortic artery than the brachial artery. Analysis showed that 
basal systolic BP was the sole significant determinant of the prone-
hypotension (p<0.001). In conclusion, these results indicate that lying in a 
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prone posture could lead to unregulated postural hypotension, which has the 
possibility of being a novel predictor of cardiovascular fragility. 
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Spine surgeries are very painful and also associated with significant 
haemodynamicpressor response. Usually these patients need a huge dose of  
higher concentration of anaesthetic agents. Higher concentration of 
anaesthetics will affect the neurological monitoring also prolongs the 
anaesthesiarecovery(12). High dose of opioids are associated with 
respiratory complication. Anaesthetic adjuncts like alpha 2 agonist will 
reduce the anaesthetic concentration thereby allow adequate neuro-
monitoring also reduce the opioid requirement and its side effects. 
Use of alpha 2 agonist in the perioperative period has been there since 
1970’s, as premedication and as an adjunct to anesthetic drugs. It is used 
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because of its sedative, anxiolytic, analgesic and its opioid sparing effect.  
Clonidine was the commonly used drug for this purpose(15,16). Recently 
Dexmedetomidine, a newer alpha 2 agonist is getting popular in anesthesia 
practice because of its more selective alpha 2 agonistic action compared to 
clonidine.(19) 
Spine instrumentation is always associated with  significant blood losses. 
Multiple factors have been suggested to influence the magnitude of this 
blood loss, which include surgical technique, operative time, number of 
vertebral levels fused, anesthetics, mean arterial blood pressure, platelet 
abnormalities, dilutional coagulopathy, and primary fibrinolysis. 
Blood-sparing techniques can be divided into two groups, based on their 
goals: they are aimed at decreasing the bleeding itself (e.g., controlled 
hypotension, local vasoconstrictors, epidural blockade) or with 
chemical/biological agents (e.g., desmopressin,aprotinin, tranexamic acid, 
epsilon-aminocaproic acid, estrogens, bone wax, hemostatic “sponges,” 
fibrin sealants)] or at decreasing the need for homologous transfusion(e.g., 
acute haemodilution, planned autologous transfusion, cell-saving systems, 
erythropoietin). 
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Controlled hypotension 
Controlled hypotension is defined as a reduction of the systolic blood 
pressure to 80-90 mm Hg, a reduction of mean arterial pressure (MAP) to 
50-65 mm Hg or a 30% reduction of baseline MAP. Pharmacological agents 
used for controlled hypotension include those agents that can be used 
successfully alone and those that are used adjunctively to limit dosage 
requirements and, therefore, the adverse effects of the other agents. 
The characteristics of an ideal hypotensive agent include easy 
administration, predictabilitywith anaesthetic agents, and lack of  side effect 
while maintaining adequate perfusion of the vital organs. 
Agents used successfully alone include inhalation anaesthetics, sodium 
nitroprusside, nitroglycerin, trimethaphancamsilate, alprostadil 
(prostaglandin E1), adenosine, remifentanil. Agents that can be used alone or 
in combination include calcium channel antagonists (e.g. nicardipine), beta-
adrenoceptor antagonists (beta-blockers) [e.g. metaprolol, esmolol].Alpha-2 
adrenergic agonists (clonidine and Dexmedetomidine) have been used 
successfully as adjuvants, oral premedication and intravenous infusion 
during anesthesia to induce controlled hypotension. 
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Physiology of adrenoreceptors 
The adrenergic receptors are a class of G protein-coupled receptors that are 
targets of the catecholamine, especially norepinephrine and epinephrine. 
Raymond Ahlquist, Professor of Pharmacology in Georgia, US was the first 
one who differentiated adrenergic receptors into alpha and beta based on 
responses of various amines in different physiological preparations (1948) 
(16). Further research on this led to sub-classification of adrenoreceptors 
based on their synaptic locations. Alpha receptors have the subtypes alpha 
1(α1) (a Gq coupled receptor) and alpha α2 (a Gi coupled receptor). Beta (β) 
receptors have the subtypes like β1, β2 and β3. All three are linked to 
Gs proteins. 
Functionally alpha 1 adrenoreceptors were found to be excitatory and alpha 
2 receptors found to be inhibitory and excitatory. Further work lead to 
discovery of three alpha 2 iso-receptors namely alpha 2a, 2b and 2c,which 
were presynaptic, postsynaptic and extra synaptic.(17) Similarly alpha1 
adrenoreceptors are further classified in to alpha 1a, 1b and 1d. 
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Distribution of alpha-2 adrenoreceptors 
The medullary dorsal motor complex in the brain stem has a high density of 
alpha2 adrenoceptors. Activation of alpha 2 receptors at this site is 
responsible for the haemodynamic response seen with this group of drugs. 
The locus coeruleus is the largest noradrenergic cell group in the brain and 
being an important modulator of wakefulness, it is the major site for sedative 
hypnotic action of alpha 2adrenoceptor agonists. The vagusnerve,as well as 
the intermediolateral cell column, substantiagelatinosaand dorsal horn of the 
spinal cord (18) have high density of alpha 2adrenoceptors. 
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Physiological effects of alpha 2 stimulation and their clinical 
implications at various system 
Respiratory System: 
Alpha 2 agonists have minimal effects on ventilation in therapeutic doses.(3) 
They do not affect hypoxic or hypercapnicventilatory drive. Do not 
potentiate the effect of opioid induced respiratory depression.(19) 
Cardiovascular system: 
The alpha 2a adrenoreceptors are primarily distributed in the periphery, 
whereas alpha 2b, 2c are in the brain and spinal cord respectively. 
Postsynaptic alpha 2adrenoreceptors are located in peripheral blood vessels 
and its stimulation by an agonist produce vasoconstriction, whereas agonist 
acts on the presynaptic alpha2 adrenoreceptors inhibit the release 
ofnorepinephrine causes vasodilatation and decrease in heart rate.(20)  
Protective reflexes triggered by reduction of blood pressure are largely 
functional despite administration of alpha 2 agonists as they do not alter 
catecholamine metabolism or block adrenergic receptors.(21) 
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Central nervous system : 
Stimulation of alpha 2 receptor by the agonist at locus ceruleus reduces the 
neuronal firing cause sedation and hypnosis. Stimulation of the alpha 2 
receptor at the dorsal motor nucleus of the medulla causes bradycardia and 
hypotension and stimulation of this receptor at the intermediolateral cell 
column and substantiagelatinosa of the spinal cord results in inhibition 
ofreleaseof the nociceptive mediator (the substance P) is responsible for its 
analgesic effect. Alpha 2 agonist action on cerebral vasculature leads to 
cerebral vasoconstrictionand decrease in cerebral blood flow.(22) 
Other physiological effects of alpha 2 receptor stimulation: 
- Diuresis due to inhibition of antidiuretic hormone release and 
antagonism ofantidiuretic hormone tubular effects. 
-    Decongestant and anti-sialogogue effects. 
-   Affects the insulin release (clinically not significant). 
 -  Decreases the adipose tissue lipolysis and increases the growth hormone  
secretion. 
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Commonly used alpha 2 adrenergic receptor agonists in the clinical practice: 
1. Clonidine 
2. Dexmedetomidine 
Clonidine 
Clonidine hydrochloride is an imidazole derivative. It was synthesized in 
early 60s, as a derivative of the known alpha sympathomimetic drug 
naphazoline and tolazoline. It was originally developed as a nasal 
vasoconstrictor. During clinical trial, it was found to cause hypotension, 
sedation and bradycardia. It was introduced in 1966 as a first 
antihypertensive  known to act on the CNS. 
Chemical Formula : 2[(2, 6 Dichlorophenyl) Imino] Imidazoline Mono 
hydrochloride 
ChemicalStucture:  
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Dose Range:  Clonidine has been used in a wide dose range for various 
studies. The clinically effective range is 2 to 7 μg/kg body weight.  
Pharmacokinetics:
 
Clonidine is rapidly and almost completely absorbed from gastrointestinal 
tract with bioavailability of 100%. After oral intake, onset of action starts 
within 30-60 minutes and peak plasma concentration is reached within 90 
min. The elimination half-life ranges between 6-24 hours with a mean of 
about 12 hours.  
Clonidine can be administered intramuscular, intravenous, transdermal, by 
nebulisation, extradural and intra-thecal routes. Rectal administration is 
known in children. It is well absorbed through skin because of its low 
molecular weight and high lipid solubility. After transdermal clonidine patch 
implantation, stable plasma concentrations are reached after 2-3 days. 
Clonidine is distributed throughout the body, the highest concentration being 
in organs of elimination i.e., kidney, gut and liver. The brain concentrations 
are low but higher than plasma concentrations.  
Clonidine is metabolised mainly by the liver to produce P-Hydroxyclonidine 
which subsequently undergoes glucuronidations to produce O-glucuronide 
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and is excreted in urine. 40 to 60 % of an orally administered dose is 
excreted unchanged in urine within 24 hours. 95 % of clonidine 
administered is excreted in urine and faeces in 72 hours and complete 
clearance occurs in 5 days. 
Uses of clonidine: 
a) As a premedicant - becauseof its sedative,anxiolytic,analgesic, and opioid 
sparing effect also it decreases the anaesthetic requirement. 
Chandrasekaraiah et al, in their study have shown that oral premedication 
with 150 mcg clonidine effectively counteracted the cardiovascular changes 
induced bypneumoperitoneum in patients undergoing elective laparoscopic 
cholecystectomy.(23) 
Study  done by Kalajdzija  et al in elective non-cardio surgical population,  
observed that patients who had clonidine  at the rate of  0.2 µg/kg/min  30 
min prior to start of surgery had considerably less stress response, which was 
shown through variation of cortisol levels during operation, glycemic levels 
and vital parameters.(24) 
Poutlu et al observed that the haemodynamic response to intubation was 
lower in clonidine premedicated patients (4.5 µg/kg)  undergoing breast 
surgery.(25) 
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Marchal et al in their study has proved that 300 µg of clonidine 
premedication reduced the isoflurane and fentanyl and urapidil requirement 
during ENT surgery, also it has reduced the  haemodynamic response to 
intubation and the surgical bleeding.(26) 
Friedberg et al in their study comparedthe propofol consumption rates in 
patients undergoing office based surgical procedure under BIS guided 
propofol-ketamine anesthesia with or without clonidine premedication 
(200µg) and observed that oral clonidine premedication reduced propofol 
requirements.(27) 
b)For controlled hypotension in reduction of surgical bleeding. 
Woodcock TE et al, in their study, observed that, the patients who 
underwent middle ear or nasal surgery with single dose oral clonidine 
premedication required lesser mean inspired isoflurane concentration  to 
induce hypotension.(28) 
In a double- blinded, randomized clinical trial, Anvari et al evaluated the 
effect of oral clonidine premedication on blood loss in lumbar spine fusion 
surgery under anaesthesia with propofol and remifentanil  and concluded 
that clonidine could reduce surgical blood loss even at the same levels of 
mean arterial pressure with control group.(29) 
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Ebnesshahidi et al , in their study on patients who underwent caesarean 
section under general anaesthesia with clonidine premedication  had  better 
hemodynamic profile and lesser  bleeding during the intraoperative period. 
(30) 
Dexmedetomidine 
Pharmacology of Dexmedetomidine 
Dexmedetomidine is an imidazole compound and is an active-isomer of 
medetomidine. It has an imidazole chain in its structure which is common to 
other alpha 2 adrenoceptor agonists. Dexmedetomidine was approved for 
human use in 1999 by the Food and Drug Administration. It was initially 
approved for sedation ofintubated and mechanicallyventilated patients in the 
intensive care setting for up to 24 hours. It wasintroduced in anaesthetic 
practice for sedation during procedures in 2008. 
ChemicalFormula: 
(+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole monohydrochloride. 
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Chemical structure: 
 
 
Dose Range: 1µg/kg as a bolus followed by 0.2-07 µg /kg/ hr. as an infusion. 
Mechanism of action of Dexmedetomidine                                                                                    
The mechanism of action of Dexmedetomidine is unique and differs from 
the currently used sedative drugs. Alpha2-adrenoceptors are found  in many 
sites, the Locus Ceruleus being, the predominant noradrenergic nuclei of the 
brainstem. Presynaptic activation of the alpha2-A adrenoceptor in the Locus 
Ceruleus inhibits the release of norepinephrine (NE)  resulting in the 
sedative and hypnotic effects and modulates nociceptive neurotransmission 
leading to analgesia. Postsynaptic activation  of alpha2-adrenoceptors in the 
CNS results in decrease in sympathetic activity leading to hypotension and 
bradycardia. Also, activation of the alpha2-adrenoceptors in the CNS results 
in an augmentation of cardiac vagal activity. Combined, these effects can 
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produce analgesia, sedation  and anxiolysis. At the spinal cord, stimulation 
of alpha2-receptors at the substantia gelatinosa of the dorsal horn leads to 
inhibition of the firing of nociceptive neurons and inhibition of the release of 
substance P. 
Pharmacokinetics: 
Dexmedetomidine has a rapidredistribution half-life  of6 minutes. It has 
volumeofdistribution of 118 litres.(31) It is highly protein bound (94%). The 
elimination half- life 1.5 to 3 hours following intravenous or 
intramuscularinjection. But it takes longer about 5-6 hours after transdermal 
application.(28) 
Dexmedetomidine demonstrates linear concentration dependent kinetics 
when given as an infusion.(28) Bioavailability is more following 
transdermal administration as compared to intramuscular route, 88% and 
73% respectively.(32) Dexmedetomidine is metabolized in the liver. It 
undergoes complete hydroxylationthrough direct glucuronidation and 
cytochrome P450 metabolism in liver and it isexcreted by kidneys as methyl 
and glucoronide conjugates.(30) Renal excretion is95% and faeces 4%. 
There are no active metabolites. 
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Pharmacodynamics: 
Following a loading dose, peak sedative effects occurs in 25 minutes.A 
biphasic cardiovascular response has been observed after the administration 
of Dexmedetomidine. An intravenous bolus of 1 mcg/kg of 
Dexmedetomidine initially results in a transient increase of the blood 
pressure due to alpha 1 receptor stimulation, a reflex fall in heart rate 
(especially in younger, healthy patients) and followed by a decrease in blood 
pressure due to the inhibition of the central sympathetic outflow. 
Dexmedetomidine induced sleep: 
Sedation due toDexmedetomidine resembles natural sleep with easy 
arousability. Dexmedetomidine hyperpolarizes the locus ceruleus, inhibiting 
the release of norepinephrine and hence produces sleep similar to that of non 
REM period. This differs from sleep produced by benzodiazepines or 
opioids. (33) 
Guo et al has done a study on rats to locate the site of action of 
Dexmedetomidine and has demonstrated that Dexmedetomidine acts directly 
on the locus cerules and produce an anti-nociceptive effect which can be 
blocked by specific α 2antagonists. The action of Dexmedetomidine also 
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resulted in the increase in activation of alpha 2 adrenoceptors in the spinal 
cord. (34) 
Side-effects 
The common adverse effects of Dexmedetomidine include hypotension, 
hypertension, nausea, bradycardia. , Rare side effects which include various 
atrio-ventricular blocks and atrial fibrillation. Most of  these adverse effects 
occur during or briefly after the  bolus  injection. 
Uses of Dexmedetomidine  in the perioperative period 
a) As a premedicant due to its sedative, 
anxiolytic,analgesic,sympatholyticand  anaesthetic sparing properties. 
b) As an adjunct to general  anaesthesia. 
c) As a sole agent for total intravenous anaesthesia. 
d) Causes significant prolongation of sensory and motor blockade when 
usedas an adjuvant in regional anaesthesia. 
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e) As an ideal agent in  monitored anaesthesia care. 
f) Effective agent for controlled hypotension due to its central and 
peripheralsympatholysis. 
The first human study by Aho et al, evaluated the effects of 
Dexmedetomidine 0.3 and 0.6 µg/kg on haemodynamic response to 
laryngoscopy and requirements of isoflurane for maintenance of anaesthesia 
in patients undergoing abdominal hysterectomy. The major findings of that 
study were that Dexmedetomidinepre-anaesthetic medication at a dose of 0.6 
µg /kg blunted the tachycardia and hypertensive response to laryngoscopy 
and endotracheal intubation. It also diminished isoflurane requirements 
during surgery.(35) 
An  observational study by Ghodki et al on patients undergoing 
laparoscopic surgeries under general anesthesia with Oxygen, Nitrous oxide 
and Isoflurane, where 1 µg/kg bolus followed by 0.2 µg/kg/hr. infusion of 
Dexmedetomidine was given during the intraoperative period. The depth of 
anaesthesia was monitored using entropy.They have observed  that there was  
a   62.5%  reduction  (0.75 mg/kg) in the induction dose of propofol, with a 
30% less end-tidal concentration of isoflurane requirement for maintenance 
of anaesthesia.(36) 
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Keniya et al in their study of isoflurane-opioid-Dexmedetomidine based 
anaesthesia have found that the need for thiopentone and isoflurane was 
decreased by 30% and 32%, respectively, in the Dexmedetomidine group as 
compared to the control group. After tracheal intubation, maximal average 
increase was 8% in systolic and 11% in diastolic blood pressure in 
Dexmedetomidine group, as compared to 40% and 25%, respectively, in the 
control group. Similarly, average increase in heart rate was 7% and 21% in 
the Dexmedetomidine and control groups, respectively. The opioid 
(fentanyl) requirement during the operation was 100±10 μg in the control 
group and 60±10 μg in the Dexmedetomidinegroup.(37) 
Khan et al has observed a dose related effect of Dexmedetomidine on MAC 
of isoflurane in his study. At plasma concentration of 0.35-0.75 ng/ml 
dexmedetomidine caused significant MAC sparing effects. Eventhough  
isoflurane  did not appear to affect the pharmacokinetics of 
Dexmedetomidine.(38) 
In a double- blind, placebo-controlled trial involving healthy male 
volunteers, the investigators found that a 2-min intravenous infusion of 
Dexmedetomidine produced a transient increase in mean arterial blood 
pressure and a longer lasting decrease inmean arterial blood pressure.(39) 
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In a study on healthy women scheduled for dilatation and curettage (D & C) 
of the uterus the authors concluded that Dexmedetomidine  pre-anaesthetic 
medication (0.5µ/kg) decreased the thiopental anesthetic requirements by 
30% and improved the recovery time from anaesthesia as measured by 
visual analogue scale with no serious hemodynamic or other adverse 
effects.(40) 
In a prospective randomized study involving patients undergoing fast-track 
CABG, Menda etal has used Dexmedetomidine as an adjunct in patients 
undergoing myocardial revascularization receiving beta blocker treatment 
and observed the attenuation of hemodynamic response to endotracheal 
intubation.(41) 
Ayoglu et al in their study determined the effectiveness  of 
Dexmedetomidine in reducing bleeding and intraoperative opioid 
requirement during septoplasty surgery under general anaesthesia. (42) 
Depth of anaesthesia. 
Various modalities are being used to measure the depth of anaesthesia in the 
perioperative period. One of such monitor which has found wide application 
in current anaesthetic practice is Bispectral index (BIS) monitor. 
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The spectral index is a statistically based, empirically derived complex 
parameter. It is a weighted sum of electroencephalographic sub parameters, 
including a time domain, frequency domain, and high order spectral sub 
parameters.  The BIS monitor provides a single dimensionless number, 
which ranges from 0 (equivalent to EEG silence) to 100 (equivalent to fully 
awake and alert). A BIS value between 40 and 60 indicates an appropriate 
level for general anaesthesia. 
The non-invasive sensor has self-adhesive backing, much like a typical EEG 
pad. The sensor then sends raw EEG information through the cable and 
converter to the BIS engine. This engine processes the EEG data according 
to an algorithm that combines select EEG features to produce a BIS index. 
Glass et al had shown that the BIS corelated well with the level of 
responsiveness and provided an excellent prediction of the level of 
consciousness with propofol,midazolam and isoflurane anaesthesia.(43) 
Kearse et al  in his study has observed that BIS could be used to predict the 
hemodynamic reponse to laryngoscopy and intubation during anaesthetic 
induction.(44) 
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BIS Monitor used to assess the Depth of Anaesthesia. 
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MATERIALS AND METHODS 
STUDY SETTING: The study was conducted in the Orthopaedics and 
Neurosurgical operating suites. 
STUDY DESIGN: A double blinded randomized control trial to compare 
the efficacy  of oral clonidine as premedication Vs Dexmedetomidine 
infusion in the perioperative period,  on anaesthetic requirements, 
haemodynamics and recovery from anaesthesia in patients undergoing 
instrumented spinal fusion. 
STUDY POPULATION:  
a. Inclusion Criteria:  
1. Adult ASA 1 and 2 patients between 18 to 60 yrs. undergoing 
elective,  two  or more than  two levels of decompression and 
instrumented spinal fusion. 
b. Exclusion Criteria: 
1. ASA 3 and 4 patients.  
2. Patients who underwent discectomy, and single level 
decompression and fusion. 
3. Patients with creatinine more than 1.5 mg% 
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4. Patients with liver dysfunction 
5. Patients who has known allergy to the drug. 
6. Pregnancy 
METHOD OF RANDOMIZATION:  
A computer generated set of randomized numbers by using block 
randomization. 
METHOD OF ALLOCATION CONCEALMENT:  
Envelops specifying only the serial no was given to the anesthesiologist, 
who anaesthetized the patient and it was noted on the data sheet. 
BLINDING AND MASKING: 
Intraoperative drug administered both,  bolus and infusion  was prepared by 
the pharmacist,  in our institution. Only the serial number on the envelope  is 
noted by the anaesthesiologist  who anaesthetized the patient  on the Data 
sheet. 
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PRIMARY OUTCOMES:  time :  Intra-operative anaesthetic requirement. 
SECONDARY OUTCOME/S: Intraoperative haemodynamic stability, 
time taken for recovery (time interval between the stopping of inhalational 
agent till the time of extubation). 
STUDY PERIOD:  
The study was conducted over a period of 9 months between February and 
October of  2012. 
TARGET SAMPLE SIZE AND RATIONALE:  
The required sample size to show a difference of 0.04 in 80% of the times 
between Clonidine & Magnesium Sulphate, a altan et al BJA 94(4):438-
41(2005) was found to be 37 in each arm with a standard deviation to be 
0.06 in each group at 5% level of significance.  
 
 
 
 
A total sample size of 74 patients were  needed for the study.  
Formula: 
 
 
 
where, s = standard deviation 
 
d = difference between the two drugs 
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SELECTION OF STUDY PATIENTS: 
Study was conducted after getting the approval from the institutional review 
board (IRB) and the ethics committee. Patients scheduled for more than two 
level of decompression and instrumented spinal fusion were included in the 
study (lumbar and thoracic). Patients who underwent single level fusion and  
discectomy were not included in the study. In our institution all patients 
undergoing surgery are seen in the pre-anaesthesia clinic by the qualified 
anesthesiologist and all our study patients who met the eligibility criteria 
were already seen and accepted for the planned surgical procedure. Those 
patients who met the eligibility criteria were approached by the 
anaesthesiologist who is involved in the study on the day before surgery and 
explained about the study in detail on their own language and got the 
consent also wrote the premedication order. 
Total of 80patients were approached, out of 80 patients, 74 were recruited 
for the study after getting the informed consent. In 4 patients, because of 
violation in the study protocol during the premedication time, study was not 
carried out.  
Eligible patients were randomly divided into two groups ,Group A  and  
Group B 
38 
 
Group A - Oral clonidine (200 µg) 60-90mins prior to induction, as 
premedication followed by saline infusion (both bolus and infusion) in a 
predetermined volume during the intraoperative period till the skin closure. 
Group B- Placebo tablet as premedication and injection of 
Dexmedetomidine 1µg/kg bolus over 10mins before induction followed by 
an infusion of 0.5 µg/kg/hr.  
ANAESTHESIA PROTOCOL: 
Premedication: 
Premedication drugs were prepared by the pharmacist in an envelope and 
numbered serially. Patients in Group A received Tablet Clonidine 200 µg 
along with Tablet Perinorm 10 mg. While patients in Group B received a 
placebo tablet along with Tablet Perinorm 10 mg as premedication.  
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Pre-induction period: 
Patients were identified by the nurse and attending anesthesiologist and 
reassessed in the preoperative holding area, brought to anaesthesia room, 
where peripheral i.v cannula( 18 or 16G) and radial arterial line (20 G) was 
inserted under local anesthesia. 
Once the operating room was ready, patient was brought to operating room. 
Standard anaesthesia monitors like NIBP, ECG, SpO2, invasive arterial line, 
BIS monitor were established. Baseline values were noted. Study drug was 
connected and the bolus dose was given over 10 minutes using the syringe 
pump which delivers the drug in ml/hr.  
Rate of bolus infusion was calculated using the following formula and it was 
given over a period of 10mins. 
Weight of the patient x 6 /5=   (n) ml/hr. for 10mins.  
Patients in Group A received 0.9% physiological saline solution while 
patients in Group B received 1µg/kg of Dexmedetomidine.  During the start 
and end of bolus injection the Heart Rate, Blood Pressure (Systolic, 
Diastolic and Mean)and BIS values were recorded. 
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Syringe pumps used for the infusion of study Drug: 
 
Monitor (Philips MP50- Intellivue) used during the study period. 
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Induction and Maintenance 
Patients were induced with fentanyl 1 µg /kg followed by propofol 1 mg/kg  
then aliquots of 10 mg of propofol boluses till the BIS value drops down 
below 60 or till the loss of eye lash reflex. Then patients are paralyzed with 
vecuronium 0.1mg/kg, after 3mins of mask ventilation, patients’ trachea was 
intubated with appropriate size ETT.Another 1 µg /kg  of  fentanyl was 
given 30 sec prior to intubation. Patients were turned prone for surgery and 
haemodynamic changes were noted.  Anaesthesia was maintained with 50% 
oxygen, air and isoflurane. Isoflurane concentration was titrated to keep the 
BIS between 40-50.  Incremental doses of i.v  morphine up to 0.1mg/kg was 
given  over a period of 30 mins after proning. Infusion of study drug was 
started as soon as the patient is turned prone. Volume of Infusion was 
calculated as follows : 
Weight of the patient/ 10= ( n)  ml/hr. , using the same infusion pump and  
infusion was continued till the  start of  skin closure.  Vecuronium was given 
as an infusion to maintain two twitches in TOF and stopped at the beginning 
of skin closure. I.V Paracetamol (1 gm.) was given prior to skin incision and 
it was repeated after 6 hrs. if the surgical time exceeds more than 6 hrs. 
Heart rate and blood pressure, end tidal  isoflurane  concentration and MAC 
of isoflurane  were noted every 15 min  till the skin closure. Number of 
episodes of hypotension and hypertension were noted during the study 
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period.Hypotension was defined as 10% drop from the pre induction value 
and hypertension was defined as 20% rise from the pre-induction value. 
Hypotension was treated with bolus dose of 5 mg of ephedrine if the heart 
rate is less than 60 or 50 -100 µg of phenylephrine bolus if heart rate is 
above 80.  Hypertension was treated with bolus dose of 0.5 mg/kg of  
propofol. If the BP is not controlled with propofol, then 0.5 µg/kg of 
fentanyl was given.  
Extubation 
At the end of skin closure  isoflurane was stopped  and  the time of stopping 
the isoflurane was  noted. After turning supine, patients were reversed with 
0.05mg/kg of neostigmine and 10 µgm./kg of glycopyrrolate. The FGF is 
increased to 6l/min. After establishing the extubation criteriapatients’ 
trachea was extubated and the time of extubation was noted.Total dose of 
fentanyl and propofol used,Duration of surgery, blood loss during surgery 
were noted. Time of stopping the study drug also noted.  
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Statistical analysis 
After collection of the necessary data, the events such as heart rate, blood 
pressure, anaesthetic requirements, episodes of hypertension, hypotension 
and bradycardia, duration of surgery, time for awakening, and  blood loss  
between two groups were compared. The mean, standard deviation and 
frequency with percentages were calculated.    
The statistical analysis was performed using  independent sample t-TEST. P 
value < 0.05 was considered statistically significant. Statistical analysis was 
performed with STATA 11.0 software (statacorp, 4505 Lakeway 
Drive  College Station, TX 77845, United States). 
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RESULTS 
Demography: 
Table 1 shows the demographic data of both the groups, Group A (clonidine 
premedication) and Group B (i.v Dexmedetomidine), which were well 
matched for age, sex, weight and duration of surgery. 
Table 1: Demographic data in each group. 
Character          Group A 
(Clonidine 
premedication) 
         Group B 
(i.vDexmedetomidine)  
Total no of patients 37 33 
Age(yrs.) 48.64±12.2 44.6±13.6 
Sex(M/F) 18/19 18/15 
Weight(kg) 60.21±6.7 59.39±8.13 
Duration of surgery of 
(hrs.) 
3.686±1.0973 3.370±0.9064 
 
There is no statistically significant difference between the two groups in 
regards to age,  sex, weight, duration of surgery. 
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Figure 1: Demographic Data.  
 
0
10
20
30
40
50
60
Group A Group B
Age
Weight
47 
 
 
Heart rate  
There is a significant difference in the baseline heart rates at the time of 
administration of the study drug bolus.Patients in Group A had lower heart 
rate compared to Group B(Table 2). The study drug was infused over a 
period of 10 minutes, A 13% decrease in heart rate was observed in the 
Group B (Dexmedetomidine)  and 3% decrease in clonidine group at the end 
of study drug infusion (at 10 minutes).At induction both groups had similar 
heart rate (Table 2 at 10 min of Bolus). There was no statistically significant 
difference in heart rate response between the two groups at proning and 5, 
15 min after proning  also at 30 min, 1hour, 2hours, 3 hours after proning. 
Demographic data like age, sex, weight were comparable between two 
groups. There was no statistically significant difference in heart rate 
response between the two groups at various time interval during the study 
period after the bolus injection.  Both agents reduced the end tidal 
concentration .The end tidal concentration of isoflurane was less . 
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Table 2: Heart rate variation between the two groups at various time 
points of the study. 
Heart rate 
Group A 
Clonidine  
Group B 
Dexmedetomidine 
P – value 
0min (start  
of study drug 
 bolus)  
80.94±14.32 89.21±19.90 0.048 
 
10 min (end   
of study drug  
bolus) 
78.37±13.11 78.45±15.05 0.982 
At  proning 82.62±19.94 78.18±15.98 0.311 
5mins after proning 79.94±14.82 76.87±15.20  0.396 
15mins after proning 74.45±11.00 73.87±14.95  0.852 
30min after proning 73.89±12.41 73.57±17.83 0.931 
1hr after proning 74.64±13.15 71.81±11.29 0.340 
2hrs after proning 77.32±12.17 75.9±11.83 0.634 
3hrs after proning 79.44±10.55  77.17±11.54 0.462 
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Figure 2:Heart rate variation between the two groups at various time points 
Systolic Blood Pressure 
There was no significant differencebetween both the groups insystolic blood 
pressure at the start of bolus study drug infusion.At the end of bolus study 
drug there was 13% decrease in systolic BPin Group B (Dexmedetomidine) 
compared to 11 %decrease in Group A (Clonidine), which is not statistically 
significant (Table 3).Both the groups had drop in systolic blood pressure 
after proning compared to the supine value. Patients in 
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Group B had more drop in BP during the bolus infusion,  at proning and 5, 
30 min after proning compared to Group A. At proning, the SBPdrop was 
20% in Group A and 30%  in Group B at  proning which was statistically 
significant (P value 0.005).Also the 5 min value after proning was 
statistically significant with the p value of 0.008. Though the 30 min value 
after proning was lower in Group B compared to Group A, it was not 
statistically significant. 
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Table3: Systolic Blood Pressure variation between the two groups at 
various time points of the study. 
SBP at 
Group A 
Clonidine  
Group B 
Dexmedetomidine 
P Value 
0min (start  
of study drug 
 bolus)  
128.51±16.80 124.12±14.18 0.573 
At 10 min (end   
of study drug  
bolus) 
115.62±26.85 109.09±24.74 0.295 
At  proning 102.67±22.77 89.51±14.11 0.005 
5min after proning 102.70±21.15 91.09±13.00 0.008 
15min after proning 103.56±20.21 98.03±13.49 0.187 
30min after proning 99.21±19.21 97.48±13.42 0.667 
1hr after proning 98.56±19.30 95.33±13.68 0.426 
2hrs after proning 98.91±17.37 99.28±18.24 0.933 
3hrs after proning 102.89±19.58 94.21±14.00  0.079 
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Figure 3: Sytolic pressure variation between two groups at various time 
points 
DIASTOLIC BLOOD PRESSURE (DBP) 
There was no significant differencebetween both the groups in diastolic 
blood pressure at the start of bolus study drug infusion. At the end of bolus 
study drug there was 13% decrease in DBP in Group B (Dexmedetomidine) 
compared to 9 %decrease in Group A (Clonidine). (Table 4) which was  not 
statistically significant. Both the groups had drop in DBP after proning 
compared to the supine value. Patients in Group B had more drop in DBP at 
5mins after proning compared to Group A. At 5mins after proning, the 
DBPdrop was 29% in Group B (Dexmedetomidine group) and 21% decrease 
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in Group A (clonidine group) from the baseline, which was statistically 
significant with a P value of 0.02.  
Table 4: Variation in DBP at various time points during the study 
period. 
Diastolic BP 
Group A 
Clonidine  
Group B 
Dexmedetomidine 
P Value 
0 min (start of study  
Drug  bolus)  
70.27±9.43 71.48±12.10 0.639 
At 10 min (end  of  
study drug bolus) 
64.97±16.52 62.48±14.89 0.514 
At  proning 59.81±15.93 53.69±11.54 0.073 
5mins after proning 59.48±12.82 53.03±1.32 0.0297 
15mins after proning 59±10.32 59±10.17 1.000 
30mins after proning 56±9.64 59.39±10.22 0.157 
1hr after proning 56.02±10.77 58.18±9.29 0.376 
2hrs after proning 58.24±10.00 58.68±10.87 0.860 
3hrs after proning 56.72±9.98 57.73±10.72 0.726 
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Figure 4: Variation in DBP at various time points during the study 
period. 
MEAN BLOOD PRESSURE (MBP) 
There was no significant differencebetween both the groups inmean blood 
pressureat the start of bolus study drug infusion. At the end of bolus study 
drug there was 12% decrease in DBP in Group B (Dexmedetomidine) 
compared to 11%decrease in Group A (Clonidine) which was not 
statistically significant (Table 5). Both the groups had drop in MBP after 
proning compared to the supine value. Patients in Group B 
(Dexmedetomidine) had 27% drop in DBP at proning compared to Group A 
(clonidine) that had 20% drop which was statistically significant withthe P 
value of 0.02. 
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Table 5: Changes in MBP between two groups at various time points of 
the study. 
Mean BP 
Group A 
(clonidine ) 
Group B 
( Dexmedetomidine) 
P Value 
0min (start of study  
Drug  bolus)  
89.54±12.21 87.24±11.37 0.420 
10 min (end  of  
study drug bolus) 
80.78±19.32 77.36±16.89 0.435 
At  proning 72.78±17.55 64.27±13.30 0.026 
5mins after proning 73.02±14.79 65.81±11.82 0.028 
15mins after proning 72.89±14.12 72.36±9.43 0.856 
30mins after proning 70.13±13.13 71.63±11.49 0.614 
1hr after proning 70.05±12.73 70.90±10.58 0.765 
2hrs after proning 71.64±11.80 72.12±13.50 0.876 
3hrs after proning 71.64±12.02 69.31±10.64 0.483 
 
Figure 5: Changes in MBP between two groups at various time points of 
the study. 
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END TIDAL ISOFLURANE CONCENTRATION (Et Iso%): 
The end tidal isoflurane concentration which required to keep the BIS 
between 40-50 was similar between the two groups at intubation, 1,5 and 15 
min after proning (Table 6). 
But there was a significant difference between the two groups were noted at 
one hour and two hours after the prone positioning with the P value of 
<0.001 at one hour and P<0.039  at two hours.The end tidal isoflurane 
concentration in group B (Dexmedetomidine) was lower compared to the 
end tidal concentration of isoflurane inGroup B (clonidine group) 
Table 6: End tidal concentration of isoflurane at various time interval: 
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Et Iso  
Group A 
Clonidine  
Group B 
Dexmedetomidine 
P Value 
At intubation 0.96±0.27 0.90±0.17 0.325 
At proning 0.92±0.24 0.91±0.22 0.869 
5mins after proning 0.86±0.21 0.85±0.21 0.928 
15mins after proning 0.80±0.16 0.74±0.17 0.121 
30mins after proning 0.82±0.17 0.75±0.14 0.060 
1hr after proning 0.86±0.17 0.72±0.12 0.001 
2hrs after proning 0.84±0.14 0.76±0.17 0.039 
3hrs after proning 0.86±0.22 0.77±0.13 0.088 
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Figure 6: End tidal concentration of isoflurane at various time interval: 
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EPISODES OF HYPERTENSION  
29 (78.4%) patients in Group A (clonidine) and 21 (63.6%) patients in 
Group B (Dexmedetomidine) did not have any hypertensive episodes (Table 
7). Hypertensive responses which needed treatment was more in Group B 
patients who received i.v Dexmedetomidine in the perioperative period 
(n=12) compared to Group A patients who received clonidine premedication 
(n=8). All of those patients who had hypertension were treated with boluses 
of propofol (0.5 mg/kg) and fentanyl (0.5 ug/kg) intravenously. 
 
Table7: Episodes of hypertension during the study period. 
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Episodes of   
Hypertension 
Group A 
(Clonidine) 
No of patients (%) 
Group B 
(Dexmedetomidine) 
No of patients (%) 
0 29 (78.4%) 21 (63.6%) 
1-3 5 (13.5%) 10 (30.3%) 
>3 3 (8.1%) 2 (6.1%) 
 
Figure : 7 Episodes of hypertension during the study period. 
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EPISODES OF HYPOTENSION  
There were 8 in each group who did not have any hypotensive episodes. 
There were 22 patients (59.5%) in Group A (clonidine) and 19 patients 
(57.6%) in Group B (Dexmedetomidine) had 1-5 episodes of hypotension. 7 
Patients (18.9%) in Group A( clonidine group) and 6 patients (18.2%) in 
Dexmedetomidine group who had more than 5 episodes of hypotension 
(Table 8). These hypotensive episodes were treated with small boluses of 
ephedrine 6mg or phenylephrine 50ugm intravenously, all patients 
responded well to the treatment and none of them had any refractory 
hypotension. 
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Table 8: Episodes of Hypotension during the study period. 
Episodes of   
Hypotension 
Group A 
(Clonidine) 
No of patients (%) 
Group B 
(Dexmedetomidine) 
No of patients (%) 
0        8  (21.6%)         8 (24.2%) 
1-5       22 (59.5%)         19 (57.6%) 
>5         7 (18.9%)         6   (18.2%) 
 
Figure : 8 Episodes of Hypotension during the study period. 
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EPISODES OF BRADYCARDIA 
35 (94.6%) patients in Group A (Clonidine) and 29 (87.9%) patients in 
Group B (Dexmedetomidine) had no episodes of bradycardia. There were 2 
patients (5.4%) in Group A (clonidine) who had 1-2episodes of bradycardia, 
out of 2 patients; one had significant bradycardia where heart rate dropped 
less than 50/min,which was treated with atropine. Although there were 4 
patients in Group B (Dexmedetomidine) who had one episodes of 
bradycardia (HR dropped < 60/min), none of them needed treatment. 
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Table 9: Episodes of bradycardia during the study period. 
Episodes of 
Bradycardia 
Group A 
(Clonidine) 
No of patients (%) 
Group B 
(Dexmedetomidine) 
No of patients (%) 
0 35  (94.6%) 29 (87.9%) 
1-2 2 (5.4%) 4 (12.1%) 
 
Figure : 9 Episodes of bradycardia during the study period. 
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TOTAL DOSE OF PROPOFOLAND FENTANYL REQUIRED 
DURING THE STUDY PERIOD. 
All study patients received 2 µg/kg of fentanyl at the time of induction and  
0.1mg/kg of intravenous morphine after proning before surgical incision and 
1gm of intravenous paracetamol for analgesia.Since adequate analgesics was 
given the hypertensive responses were treated initially with 0.5mg/kg of 
bolus dose of propofol, if blood pressure did not come to baseline value  
within few minutes then fentanyl (0.5µg/kg) bolus was given. 
The total dose of propofol and fentanyl was given during the intraoperative 
period was  converted as mg/kg and µg/kg respectively. There were no 
significant difference between two groups in the dose of propofol  and 
fentanyl consumption(Table 10). 
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Table 10: Total dose of fentanyl and propofol during the study period. 
Total Dose 
Group  A 
(clonidine) 
Group  B 
(Dexmedetomidine) 
P   value 
Fentanyl 
(µg/kg) 
3.14±0.93 2.83±1.05 0.206 
Propofol 
 (mg/kg) 
2.35±0.94 2.46±1.03 0.644 
 
Figure : 10 Dose of fentanyl and propofol used . (Mean) 
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TIME OF AWAKENING 
The time taken between stopping of inhalational agents to the time of 
extubation was taken as awakening time. Awakening time was 
9.81±5.15min for the Group A (Clonidine) and 8.51±3.79 min for Group B 
(Dexmedetomidine).  But this difference was not statistically significant. 
 
Table 11: Awakening Time  
 
 
Group  A 
(clonidine) 
Group  B 
(Dexmedetomidine) 
P   value 
Time of Awakening 
       (minutes) 
9.81±5.15 8.51±3.79 0.239 
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DURATION OF SURGERY AND THE INTRAOPERATIVE BLOOD 
LOSS 
The average duration of surgery was comparable for both groups. The 
average amount of blood loss in Group A (Clonidine) was 350 ± 218 ml 
while in Group B (Dexmedetomidine) was 340 ± 103 ml. The blood loss 
was comparable between two groups. 
Table 12: Duration of Surgery and Blood loss: 
 Group  A 
(clonidine) 
Group  B 
(Dexmedetomidine) 
Duration of Surgery 
      (hours) 
3.68±1.09 3.37±0.90 
Average blood loss 
(millilitre)  
350 ± 218 340 ± 103 
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DISCUSSION 
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DISCUSSION 
Recently there has been a great interest in use of perioperative systemic α 2 
agonists to decrease the peri-operative opioid consumption, pain intensity, 
and nausea. There have been various studies on clonidine or 
Dexmedetomidine andits effects on anesthetic requirement, 
haemodynamicsand intra operative and post- operative opioid requirement 
comparing with placebo. There was no study comparing the effect of 
clonidine VsDexmedetomidine onanaesthetic requirement and 
haemodynamics and recovery from anesthesia.  
Clonidine has been used in anesthesia practice for long time, but 
Dexmedetomidinehas been introduced in anaesthesia practice very recently 
and getting popular for its more selectivity on the alpha 2 receptor (8 times 
more compared to clonidine). Because of more selectivity, the complication 
of alpha 2 agonist induced side effects like hypotension and hypertension 
and bradycardia are less  also it has shorter  half- life (1.5 -2 hrs.)  compared 
to clonidine (8-12 hrs.). 
 In our study we have compared the effects of two different drugs on the 
same pharmacological group given through two different routes because of 
the following reason: 
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1. Clonidine has 100% bioavailability after oral administration with an onset 
of action at 30- 60 mins with the peak action at 90mins and the elimination 
half -life of 12 (mean) hrs. Because of this pharmacological property oral 
preparation is as effective as intravenous drug. 
2. The oral form of clonidine is cheaper and easy to administer with less side 
effects compared to intravenous clonidine where the drug has to be given 
slowly as an infusion need intravenous line and syringe pump and monitors 
to check the vital signs during the  during the bolus infusion.  
3. In our institution, it is a routine practice to give oral clonidine 
premedication for spine surgeries where there is no contraindication for 
giving this drug, to provide controlled hypotension and to reduce the 
haemodynamic response during the painful stimuli so we wanted to compare 
this routine technique with the newer alpha 2 agonist, the  
Dexmedetomidine. Since oral preparation of Dexmedetomidine was not 
available, also it has shorter duration of action we have decided to give an 
intravenous  bolus followed by an infusion. 
 Both the drug effects were comparedon the anaesthetic requirement, 
haemodynamic effects during surgery and recovery from anaesthesia in 
patients undergoing two or more levels of instrumented spinal fusion. 
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Effect on anaesthetic requirement: 
In our study we have used BIS  monitor to assess the depth of Anaesthesia. 
End tidal Isoflurane concentration (Etiso %) was titrated to keep the BIS 
between “40-60”. We found that the Et iso (% ) concentration was similar 
between the two groups during intubation, at after prone position, and 15 
min after prone position. At 30 min, 1 hr.  and 2 hrs. after prone position, the 
isoflurane concentration to keep the BIS between 40-60 was significantly 
less in the Dexmedetomidine group compared to clonidine premedication 
group. This can be explained by, the peak effect of Dexmedetomidine takes 
30 min after intravenous administration that is why, the Et iso concentration 
till 30mins after prone position was similar in both the groups after 30mins 
there was a significant reduction in Et iso concentration till 2 hrs.  
Administering the Dexmedetomidine 30 min prior to starting of surgery 
could have produced significant reduction in Etiso from the beginning but 
this was not feasible in our study.  
Both the groups had reduction in Etiso from 1.15% (to produce 1 MAC) 
which is considered to be the standard concentration to produce 1 MAC. 
Since we did not have the placebo group to compare we have taken the ET 
iso of 1.15% as base line and calculated the difference. At intubation there 
was 17% (Et 0.96)reduction in Et iso concentration in clonidine group and 
22% (Et iso 0.9%) reduction in Et iso concentration in 
72 
 
Dexmedetomidinegroup compared to the baseline value. 1 hour after prone 
position there was a reduction of about 26% (Et iso 0.86%) in clonidine 
group, and 38% (Et 0.72%) reduction in Dexmedetomidine group compared 
to base line. At 2 hrs. of after prone position there was 27% (0.84%) 
reduction in clonidine group and 34% (Etiso 0.77%) in Dexmedetomidine 
group.  
Woodcock TE et al in their study observed that, with single dose of 
clonidine premedication (600 µg) reduced the isoflurane concentration from 
2.3% in control group to 1.4%  in clonidine group  to produce controlled 
hypotension (40% reduction in Et iso) in patients undergoing ENT surgery.  
Marchal JM et al in their study observed that, with single dose of clonidine 
premedication (300µg) reduced the mean isoflurane concentration from 
1.01% in control group to 0.63% in clonidine group to produce controlled 
hypotension (37% reduction in Et iso) in patients undergoing ENT surgery.  
In our study weobserved that, with single dose of clonidine premedication 
(200µg) reduced the Et iso % by 26, 27 % during surgery at 1 hr. 2hrs). 
Khan et al studied the effect of two different concentration of 
Dexmedetomidine infusion on isoflurane requirement in healthy volunteers 
to tetanic stimulus. They have proved that the Et Iso was o.52% (50% 
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reduction compared to placebo) in volunteers who received 1.35ug/kg/hr., 
Etiso was 0.74 % ((29% reduction compared to placebo) when they have 
received 0.3 ug/kg/hr.  
Ghodki et alstudied the effect of Dexmedetomidine on isoflurane 
requirement on patients undergoing laparoscopic surgeries under general 
anesthesia with Oxygen, Nitrous oxideand Isoflurane, where 1 µg/kg bolus 
followed by 0.2 µg/kg/hr. infusion of Dexmedetomidine was given during 
the intraoperative period. They have observed  that there was  a   62.5%  
reduction  (0.75 mg/kg) in the induction dose of propofol, with a 30% less 
end-tidal concentration of isoflurane requirement for maintenance of 
anaesthesia. 
Aho et al studied the effect of Dexmedetomidineinfusion onanaesthetic 
requirement in patients undergoing surgery under isoflurane + N2O 
anaesthesia and proved reduction in isoflurane concentration was more than 
90%. This may be due to the combination of N2O with isoflurane. 
In our study we have observed that, with 1µg/kg bolus followed by  0.5 
µg/kg/hr.Dexmedetomidine there is 35-38% reduction in anaesthetic 
concentration during  surgery ( at 1hr, 2 hrs.)  under isoflurane, air, oxygen 
anaesthesia. 
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Reduction in Anaesthetic concentration was comparable with other studies 
using clonidine and Dexmedetomidine separately comparing with placebo. 
We want to conclude that both the agents reduce the anaesthetic requirement 
but theDexmedetomidinereduces more compared to clonidine. This 
reduction was statistically significant. 
Haemodynamic response : 
Heart rate:Both clonidine premedication and Dexmedetomidine infusion 
are known to attenuate the heart rate response to surgical stress. In our study, 
throughout the study period both groups had comparable heart rate ranging 
from 70-80/min, which explains that both, clonidine and Dexmedetomidine 
attenuate the heart rate response related to surgical stress. 
There was a significant difference in the baseline heart rates at the time of 
administration of the study drug bolus between two groups. This can be 
explained by, Patients in clonidine grouphad premedication (clonidine 200 
µg), and so their heart rate was lower compared to patients in 
Dexmedetomidine group where, none of them had premedication. At the end 
of bolus infusion there was no difference in heart rate was noted between the 
two groups. During surgery both groups had comparable heart rates, there 
was no significant difference between two groups. 
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Since we did not have placebo group to compare the heart rate from 
baseline, the % change was not calculated for the clonidine group. 
Dexmedetomidine group did not receive any premedication, so the base line 
heart rate was compared with the heart rate after the bolus injection and the 
% change was calculated. There was 13% reduction in heart rate after the 
bolus injection (1 µg/kg). It was statistically significant. 
Blood pressure:  
The blood pressure changes could be attributed to various factors such as 
prone positioning, anaesthetic induced vasodilatation, surgical blood loss 
and the use of alpha 2 adreno receptor agonistic activity. Since all the 
parameters were comparable between the two groups except the use of two 
different drugswe have compared the haemodynamic effects between two 
groups.   
In our study both clonidine and Dexmedetomidine both reduced the blood 
pressure. During the bolus injection of Dexmedetomidine, there was 13%, 
13%, 12% reduction in the systolic, diastolic and mean blood pressure 
respectively. While in clonidine group there was 11%, 9%,12% reduction in 
systolic, diastolic and mean blood pressure respectively. 
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At 1 hr. after proning, during surgery when the Dexmedetomidine infusion 
was going on at 0.5µg/kg/hr. there was 25%, 18%, 20% reduction in 
systolic, diastolic and mean blood pressure respectively. While in clonidine 
group there was 24%,  20%, 22% reduction in systolic, diastolic and mean 
blood pressure.  
At 2 hrs.and 3 hrs. after proning, the  blood pressure reduction was 
comparable between two groups.  
At the time of proning to 15 min after proning, the blood pressure drop was 
more significant in Dexmedetomidine group compared to clonidine group 
this may be due to the peak effect of Dexmedetomidine effect on the blood 
vessels. 
We want to conclude that both the drugs were very effective to produce 
controlled hypotension during surgery, since the drop was more significant 
till 15 min after prone position in Dexmedetomidine group, we have keep 
this in our mind and treat the blood pressure promptly before it drops down 
significantly. 
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Propofol and Fentanyl requirements during the study period:  
There was no significant difference between the two groups  in requirement 
of propofol or fentanyl during the study period . The total dose of fentanyl 
given during the study period was 3.1 µg/kg in the clonidine group and 
2.8µg/kg in theDexmedetomidine group.  
The total dose of propofol given during the study period was 2.3 mg/kg in 
clonidine group and 2.4mg/kg in Dexmedetomidine group. 
This result signifies that both clonidine and Dexmedetomidine reduce the 
analgesic and propofol requirement effectively.  
Intraoperative blood loss:  
Clonidine and Dexmedetomidine are the drugs commonly used to produce 
controlled hypotension by virtue of their alpha 2 agonistic action. In our 
study blood loss was comparable between both the groups. The mean blood 
loss was 350 ml in clonidine group and was 340 ml in Dexmedetomidine 
group.  
In a double- blinded, randomized clinical trial, by Anvari et al evaluated the 
effect of oral clonidine premedication (200µg) on blood loss in lumbar spine 
fusion surgery under anaesthesia with propofol and remifentanil. The Mean 
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blood loss in the clonidine group was 422 ml compared to control group 
where the mean blood loss was 749 ml. 
In our study we the mean blood loss was 350 ml which was comparable with 
Anvari et al study.  
El-gohary and his associate compared the efficacy of Dexmedetomidine with 
sodium nitroprusside as hypotensive agent in scoliosis surgery and found 
that the blood loss andtransfusion requirement were significantly lower in 
the Dexmedetomidine group.  
In a double- blinded, randomized clinical trial, by Anvari et al evaluated the 
blood loss in patients undergoing lumbar spine fusion surgery, where the 
mean blood loss in the control group was 749 ml, taking this as control the 
mean blood loss in patients who received Dexmedetomidine was 340 ml.  
We want to conclude that both clonidine and Dexmedetomidine was equally 
effectiveto produce controlled hypotension thereby reducing the blood loss.  
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Awakening Time: 
The awakening time was measured in minutes from the time of stopping of 
isoflurane to the time of extubation.  The mean awakening time was 9.8 min 
in clonidine group and 8.5 min for Dexmedetomidine group. There was no 
significant difference in awakening time between the two groups.  
We conclude that both, clonidine and Dexmedetomidine do not cause delay 
in recovery from anaesthesia. 
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COMPLICATION 
Hypotension and bradycardia were the common complications noted after 
administration of alpha 2 receptor agonist. Hypertension is reported during 
the administration of bolus dose of Dexmedetomidine because of vaso-
constrictiveeffect on the blood vessel. In our study, out of 33 patients who 
received Dexmedetomidine only one patient (3%) had hypertensive response 
during the bolus injection which was settled down on its own within 5mins. 
There were 2 patients (5.4%) in clonidine and 4patients (12.1%) in 
Dexmedetomidine group who had bradycardiaepisodes  (HR<60/min). 
None of these patients except one in clonidine group whose HR was dropped 
to 45/min needed treatment with atropine.  
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CONCLUSION 
Both clonidine and Dexmedetomidine reduces the endtidal concentration of 
Isoflurane but the Dexmedetomidine reduces more significantly compared to 
clonidine. Intraoperative requirement of propofol and fentanyl was same 
with both clonidine and Dexmedetomidine.  
Both clonidine and Dexmedetomidine effectively control the heart rate in the 
intraoperative period. Both the drugs were very effective to provide 
controlled hypotension during surgery. But there is a significant drop in 
blood pressure at the time of proningand 5 min after proning 
inDexmedetomidine group compared to clonidine group. The recovery from 
anaesthesia was not delayed in both the groups.  
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                                          ANNEXURES 
PROFORMA 
Name :                                                                          Age/sex :                                
Hospital No :                                                                 Serial No : 
Preinduction BP: 
Study drug  (Bolus)  time of starting:                              
Infusion starting time :                           Stopping time : 
Time of stopping the isoflurane :                                 Time of Extubation : 
Time taken for recovery:                                      Duration of surgery : 
Total Propofolused : 
Haemodynamic Variables during the intra operative period. 
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Time HR/ min 
BP    (mm of Hg) 
(syst/dias/mean) 
End 
tidal 
Iso 
MAC 
of Iso 
BIS 
0 min(baseline)      
 5 min (after 
Bolus) 
     
10 min      
15 min      
20 min      
After proning 
(Immediately) 
     
5 min after      
10 min      
15 min       
30 min      
45 min      
 1 hr.      
1 hr. 15 min      
1 hr. 30 min      
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1 hr. 45 min      
2 hr.      
2 hr. 15 min      
2 hr. 30 min      
2hr 45 min      
3 hr.      
3 hr. 15 min      
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ABREVATIONS  
α 2 agonist -  Alpha 2 agonist 
ASA-  Amrican Society of Anaesthesiologists 
BIS – Bi Spectral index 
CABG – Coronary Artery Bypass Graft 
CNS – Central Nervous System 
D&C – Dilatation And Curettage 
DBP – Diastolic Blood Pressure 
ECG -Electro Cardio Graph 
EEG –Electro Encephalo Gram 
Et Iso- End Tidal Isofluorane 
ETT – Endo Tracheal Tube 
FGF – Fresh Gas Flow 
IRB – Institutional Review Board 
IV – Intra Venous 
MAP – Mean Arterial Pressure 
MBP – Mean Blood Pressure 
ml – millilitres 
mg/kg – milligram per kilogram 
mm hg – millimeters of mercury 
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µgm – microgram 
µgm/kg – microgram per kilogram 
µgm/kg/hr – microgram per kilogram per hour 
mins – minutes 
MAC – Minimum Alveolar Concentration 
NIBP – Non Invasive Blood Pressure 
NSAID - Non Steroidal Anti Inflamatory Drugs 
PONV – Post Operative Nausea Vomiting 
REM – Rapid Eye Movement 
Sl.No – Serial Number 
SBP – Systolic Blood Pressure 
Vs - Versus 
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Department of Anaesthesia 
CMC hospital Vellore, Tamilnadu 
Informed consent form no ............... 
Patient information sheet 
1. The title of my research is “A randomized control trial to compare the effect of Dexmedetomidine 
infusion in the perioperative period Vs oral clonidine as premedication, on anaesthetic 
requirements, haemodynamics and recovery from anaesthesia in patients undergoing major spine 
surgery.” 
 
Person carrying out research: Dr.Hari Narayana Prabhu 
 I’m Dr.Hari Narayana Prabhu, a senior registrar working in the department of 
Anaesthesia, CMC Vellore. I’m doing a research study to compare the effect of 
Dexmedetomidine on heart rate, blood pressure changes, anesthetic requirement and recovery 
from anaesthesia with Tab. Clonidine as premedication in patients undergoing major spine 
surgery 
 
 I am going to give you information and invite you to be part of this research. You do not 
have to decide today whether or not you will participate in the research. Before you decide, you 
can talk to anyone you feel comfortable with about the research.  
 
There may be some words that you do not understand. Please ask me to stop as we go 
through the information and I will take time to explain.  If you have questions later, you can ask 
me or the anaesthesiologist on the day of surgery. 
 
Purpose of the research: 
 Spine surgery is associated with lot of bleeding, fluctuations in blood pressure and heart 
rate during the surgery. Usually these surgeries will take approximately about 4 hours. There are 
techniques used to reduce the bleeding, swings in the blood pressure and heart rate and faster 
recovery from anaesthesia. One of these techniques is using a particular group of drug (Alpha 2-
adrenoceptor agonist) to provide drop in blood pressure in a controlled manner. This technique 
helps the surgeon to performthe operation faster because of the bloodless field which in turn 
reduces the blood loss and operative time, also helps the patients to recover fast from anaesthesia. 
 
100 
 
One of the drugs in this group is clonidine and it has been in use during or before surgery 
for a considerable period of time for reducing the blood pressure in a controlled manner. It also 
produces sedation and pain relief. Dexmedetomidine is a new drug, which produces good pain 
relief and sedation and compared to clonidine because it acts on the specific site and is thought to 
produce less side effects. Both these drugs are being used in anesthetic practice. In this study we 
are comparing the two to see if Dexmedetomidine is superior to Clonidine in reducing the amount 
of anaesthesia drug needed to keep you in a sleep state during surgery, blood pressure and heart 
rate changes and the time to waking up from anaesthesia.  
 
You are being requested to participate in thisstudy, if you give your consent the above 
mentioned medications will be given to you based on random allocation. You will receive either 
of the drugs. 
 
I plan to include patients who undergo surgery on the spine or back bone. Your 
participation in this study is purely voluntary and you can withdraw from the study at any time, 
even immediately before the surgery. Your refusal to participate will not involve any penalty or 
loss of benefits to which you are otherwise entitled. If you choose not to participate in this 
research project, you will receive the routine treatment for this operation. 
 
Confidentiality: your name will not be mentioned anywhere neither the data sheet nor the final 
published study. Your data will bear a study number and the number will be used till analysis. 
The master sheet will have your study number.  
Reimbursements: You will not be charged the cost of Dexmedetomidine. There are no other 
incentives.  
Sharing of the result: The results of research are property of Christian medical college and I'm 
entitled to publish it in a journal or present in a conference. 
 
This proposal has been reviewed and approved by [IRB, ChristianMedicalCollege], which 
is a committee whose task it is to make sure that research participants are protected from harm.  If 
you wish to find about more about the IRB,  
 
Contact  
Research Office, 
Second floor,Carman block,  
ChristianMedicalCollege,  
Bagayam, Vellore 632002.  
Email: research@cmcvellore.ac.in, Telephone: 04162284294.  
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It has also been reviewed by the Ethics Review Committee CMC Vellore, which is supporting the 
study.  
 
In case of doubts or questions, please contact Dr.Hari Narayana Prabhu, Department of 
Anaesthesia, ChristianMedicalCollege and Hospital, Vellore. Ph.No. 9894726616. 
PART II: Certificate of Consent 
 
 I have read the foregoing information/ it has been read to me. I have had the opportunity 
to ask questions about it and any questions that I have asked have been answered to my 
satisfaction.  I consent voluntarily to participate as a participant in this research. 
 
Print Name of Participant__________________   
Signature of Participant ___________________             
Date ___________________________                             
              Day/month/year                                                                                     
     
 
If illiterate Thumb impression (R / L) 
 
I have witnessed the accurate reading of the consent form to the potential participant, and 
the individual has had the opportunity to ask questions. I confirm that the individual has 
given consent freely.  
 
Print name of witness_____________________             and     Thumb print of 
participant 
Signature of witness ______________________ 
Date ________________________ 
                Day/month/year 
 
Statement by the researcher/person taking consent 
I have accurately read out the information sheet to the potential participant, and to the 
best of my ability made sure that the participant understands that the following will be 
done: 
1. Inj. Dexmedetomidine or Placebo will be given during surgery.  
2. Participation is voluntary and cost of Dexmedetomidine will be borne by the research 
fund. 
 
I confirm that the participant was given an opportunity to ask questions about the study, 
and all the questions asked by the participant have been answered correctly and to the 
best of my ability. I confirm that the individual has not been coerced into giving consent, 
and the consent has been given freely and voluntarily.  
A copy of this ICF has been provided to the participant. 
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Print Name of Researcher/person taking the consent-Dr. Hari Narayana Prabhu   
Signature of Researcher /person taking the consent__________________________ 
Date ___________________________  
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1 49 f 104628f A 52 72 83 68 60 76 60 62 77 78  
2 67 m 160880f B 63 70 66 71 68 77 79 80 83   
3 64 f 053843f A 65 71 72 82 84 73 66 99 100   
4 22 m 127066f B 62 67 70 60 58 64 62 56 58 59  
5 54 f 713103a A 59 96 86 87 84 80 81 79 76 74  
6 42 m 157074f A 49 77 74 78 76 67 62 64 72 75  
7 70 m 717610c A 52 105 85 96 93 85 93 92 88 93  
8 67 f 965929d B 58 106 93 92 86 78 76 72 101   
9 47 f 680932d B 50 115 89 84 74 63 65 60 74 78  
10 30 f 121732f B 60 87 73 71 66 65 64 63 71 90  
11 51 m 653116b B 58 113 82 110 102 89 93 88 88 96  
12 39 m 879161b B 64 100 80 78 79 76 77 81 77 83 85 
13 58 f 172604f A 65 79 69 68 69 74 70 71 81 85 86 
14 38 m 844513c A 68 110 109 108 101 97 95 93 90 88 96 
15 48 f 192654f B 45 88 69 84 93 92 77 81 74   
16 48 m 182444f A 52 67 71 163 117 76 59 75 73   
17 35 f 210134f B 63 137 137 76 63 125 148 56 68 72  
18 41 f 220853f A 61 116 95 103 93 93 86 84 82 85 91 
19 35 f 167725f B 57 106 82 67 68 69 66 69 71   
20 61 m 188599f A 59 79 82 54 61 55 54 59 61 63 61 
21 51 f 226019f B 54 95 80 75 76 71 68 69 71 70 73 
22 67 m 223565f A 58 74 69 82 90 87 72 73 72 78 70 
23 55 f 420646d B 52 91 91 96 94 94 96 86 86 90 100 
24 55 f 086919f A 70 85 80 84 65 64 68 68 76   
25 42 m 224638f A 60 70 68 88 96 87 92 88 96   
26 
   
B 
  
         
27 31 f 232624f A 57 75 106 92 88 82 82 69 85 93 106 
28 55 m 031686f B 50 65 57 63 61 51 56 62 73 83 84 
29 56 m 232947f A 56 71 66 70 62 63 66 62 67 71  
30 55 f 549851c B 62 70 61 75 66 65 62 64 64 67  
31 72 m 827619c B 49 64 66 65 61 56 55 57 56 61 65 
32 46 f 237765f A 50 73 73 71 71 63 64 75 74 77  
33 23 m 221451f B 54 72 70 61 63 60 65 90 63 72 70 
34 18 m 240733f A 60 76 74 89 99 80 76 80 87 94 96 
35 27 f 226165f A 56 67 70 60 58 64 62 56 58 59  
36 29 m 231639f B 70 82 78 69 72 66 66 64 87   
37 43 m 239359f A 62 76 70 84 82 76 68 75 72   
38 
   
B 
  
         
39 56 m 201771f B 49 72 69 66 76 77 76 68 72 72  
40 63 f 201598f A 51 85 79 69 70 66 80 64 64 70 75 
41 37 f 230208f A 60 68 78 62 70 61 98 65 62 78  
42 50 m 254932f B 53 100 95 106 99 82 84 85 92   
43 46 m 235105f B 50 100 87 76 70 61 62 66 63 68  
44 54 f 242501f A 61 68 55 50 49 51 52 57 58 65  
45 40 m 172876f A 75 75 68 75 73 77 87 85 93 76 78 
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1 
 
118 111 80 84 84 88 85 98 92   68 72 62 64 51 
2 
 
104 71 76 76 101 90 100 109    50 41 42 40 57 
3 
 
140 132 124 124 138 132 126 136    72 73 64 65 61 
4 
 
116 111 63 89 94 104 84 86 84   80 87 35 45 57 
5 
 
124 138 85 84 93 80 85 74 122   71 75 53 55 63 
6 
 
113 130 92 92 97 94 93 94 91   68 90 59 61 64 
7 
 
124 95 126 126 89 107 108 110 111   75 51 74 74 52 
8 
 
139 140 126 122 115 105 103 160    76 71 86 70 67 
9 
 
156 121 91 87 124 84 101 101 100   88 78 56 52 74 
10 
 
114 86 79 87 91 76 98 94 91   64 47 47 47 54 
11 
 
122 85 85 85 87 103 78 86 97   64 36 38 41 53 
12 90 140 128 100 100 98 100 97 118 103 113 108 89 79 60 61 61 
13 
 
112 68 96 76 83 84 80 113 114 115  66 45 53 76 45 
46 44 f 021234f B 64 65 60 65 61 59 57 70 71   
47 49 m 225571f A 69 78 66 67 67 65 65 63 67   
48 31 f 237531f B 56 93 94 83 81 70 62 61 68 69  
49 60 m 752029d A 66 82 84 96 91 92 89 93 97 93  
50 47 f 256759f B 62 67 68 54 53 56 54 58 62 68  
51 28 m 261541f B 63 130 99 115 105 87 95 88 99 89 81 
52 52 f 254209f A 53 79 81 105 99 72 66 69 74 86 83 
53 42 f 025185f A 59 76 70 67 68 61 56 60 70 70  
54 21 f 253949f B 50 108 90 87 78 71 65 64 65 71 74 
55 39 m 269370f A 60 50 49 74 74 77 70 68 73 77  
56 39 f 251257f A 61 72 77 94 95 72 66 81 61 70  
57 39 m 277192f B 75 103 77 80 80 79 71 67 74 75  
58 57 m 216662f B 63 113 82 110 102 89 93 88 88 96  
59 45 f 179150f A 61 94 85 88 89 74 74 65 68   
60 59 m 137430f B 70 74 68 70 68 62 61 65 66 66  
61 44 f 265754f A 59 75 79 70 77 70 71 62 66 67  
62 45 f 255939f B 70 70 68 60 100 90 80 88 91   
63 34 m 085900d B 74 66 68 100 106 70 73 70 87 98 95 
64 62 m 281585f B 52 82 78 69 72 66 66 64 87   
65 72 m 297409f A 50 85 77 81 81 81 82 101 96 101  
66 62 f 647712o A 69 80 75 71 79 66 67 73 88   
67 49 f 219570f A 65 90 90 110 99 94 95 107 97 91  
68 42 m 269108d A 77 80 77 74 74 73 78 74 69 75  
69 33 m 198291f B 72 82 69 72 67 91 86 82    
70 40 f 287983f B 66 91 73 70 69 67 68 88 80 82  
71 67 f 192733f A 58 116 109 93 86 85 84 84 85 85 87 
72 42 m 231762d A 63 103 99 84 68 76 78 67 86 87  
105 
 
14 
 
144 140 106 109 93 80 78 90 94 96  78 78 61 73 60 
15 
 
125 200 100 94 107 95 92 113    88 100 74 72 82 
16 
 
107 95 137 106 78 90 79 71    57 58 88 75 56 
17 
 
93 68 84 75 73 89 64 66 82   54 34 69 46 45 
18 94 150 92 136 117 118 113 129 103 101 105 116 84 67 95 75 76 
19 
 
115 101 107 98 120 124 120 113    65 79 52 50 67 
20 64 136 136 98 92 88 88 74 92 100 94 103 71 72 52 48 53 
21 
 
120 98 85 83 89 85 89 85 84 86  67 54 48 41 50 
22 60 108 107 112 150 156 90 126 88 113 101 85 75 66 43 70 72 
23 
 
108 90 120 116 121 124 103 90 140 103  46 45 60 64 67 
24 
 
123 136 75 68 77 70 82 74    64 83 58 52 57 
25 
 
114 102 110 92 123 111 103 104    60 59 77 47 81 
26 
 
                
27 
 
95 89 87 85 79 77 93 94 84 95  52 57 50 50 45 
28 
 
121 108 85 78 122 100 85 83 100 104  84 54 46 44 62 
29 
 
123 67 81 107 119 117 95 128 128   57 36 34 51 56 
30 
 
141 114 98 77 95 91 87 88 94   74 59 64 46 61 
31 
 
146 118 81 77 73 74 95 87 75 81  61 53 52 51 48 
32 
 
140 89 87 99 119 118 78 97 97   90 52 57 65 72 
33 68 107 104 80 81 90 100 85 93 87 94 103 58 54 48 39 40 
34 91 98 94 104 115 90 85 79 79 84 82 89 57 51 61 75 53 
35 
 
116 111 63 72 94 104 84 86 84   80 87 32 35 57 
36 
 
137 124 89 91 100 91 90 119    72 68 49 53 62 
37 
 
146 143 154 129 120 88 113 92    80 82 82 84 78 
38 
 
                
39 
 
140 116 72 90 93 103 102 90 90   90 74 40 46 47 
40 77 140 140 86 85 118 156 118 110 136 116 121 67 64 49 50 60 
41 
 
134 106 90 87 89 100 93 100 89   70 60 55 56 53 
42 
 
115 113 100 105 100 110 106 128    74 69 67 71 58 
43 
 
130 114 70 108 103 98 122 87 108   70 65 50 69 67 
44 
 
160 180 80 79 89 97 105 100 165   82 68 40 39 47 
45 
 
96 94 99 100 130 120 106 130 95 90  60 63 60 58 78 
46 
 
109 139 88 93 104 123 112 121    66 75 51 47 51 
47 
 
128 105 80 103 109 90 77 89    78 55 68 75 68 
48 
 
125 120 104 95 91 93 86 90 94   60 60 50 53 50 
49 
 
125 120 76 91 134 103 94 104 97   58 57 44 45 57 
50 
 
119 73 98 87 93 80 82 88 108   73 57 49 46 47 
51 
 
106 87 84 61 87 125 89 111 78 83  88 60 63 45 60 
52 83 113 120 150 150 120 114 110 105 80 85 84 62 68 90 90 70 
53 
 
121 110 99 108 88 80 83 88 103   65 61 55 66 50 
54 
 
137 119 90 87 91 90 96 100 90 96  81 73 51 52 58 
55 
 
150 126 115 108 110 120 99 124 119   72 61 54 50 55 
56 
 
128 80 106 149 99 73 111 96 102   73 40 57 50 46 
57 
 
140 111 101 109 86 107 113 82 74   80 66 67 73 75 
58 
 
122 85 85 85 87 103 77 86 97   64 36 36 41 53 
106 
 
59 
 
144 138 99 105 81 80 76 100    78 68 62 59 52 
60 
 
132 85 85 110 123 90 77 88 100   70 64 64 82 83 
61 
 
135 146 97 96 120 130 105 106 84   67 75 60 55 66 
62 
 
111 105 60 91 89 95 93 97    64 73 40 61 63 
63 94 127 127 96 105 92 86 123 115 104 100 91 63 62 64 55 58 
64 
 
137 124 89 91 100 91 90 114    72 68 49 53 62 
65 
 
141 116 147 130 131 127 153 106 98   59 48 58 56 52 
66 
 
151 87 70 100 81 91 98 131    87 54 40 51 42 
67 
 
149 146 122 114 120 106 144 108 131   73 72 100 58 72 
68 
 
129 84 115 96 99 96 99 103 101   65 44 54 56 55 
69 
 
123 107 97 84 109 106 109     95 59 56 44 60 
70 
 
119 108 86 89 87 82 98 89 87   69 62 49 50 48 
71 
 
150 173 111 74 88 83 90 80 92 83  75 127 46 47 50 
72 
 
130 132 104 98 88 89 96 57 77   84 65 66 45 58 
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1 52 49 59 56   82 87 58 59 62 64 60 71 68   0 
2 53 58 56    66 49 51 51 68 63 69 62    0 
3 60 92 92    95 92 82 81 90 84 108 110    0 
4 65 51 48 45   89 91 47 53 74 82 65 62 60   0 
5 52 59 47 76   84 83 61 62 70 59 65 53 85   0 
6 60 62 57 53   86 92 71 73 76 72 68 71 68   0 
7 60 60 61 62   86 66 94 94 64 76 76 77 80   0 
8 64 64 82    90 98 112 93 86 79 78 114    0 
9 42 58 60 73   103 97 69 65 94 57      0 
10 43 53 50 54   75 58 56 59 66 51 67 69 68   0 
11 64 46 52 58   87 53 53 60 66 80 57 66 72   0 
12 63 74 71 60 64 61 113 94 72 74 74 76 83 88 74 81 77 0 
13 46 44 63 64 69  77 51 67 52 58 59 56 80 81 80  0 
14 52 52 60 59 61  110 109 83 85 72 60 58 70 71 80  0 
15 69 75 83    97 129 81 77 88 75 79 90    0 
16 55 51 45    70 66 107 86 37 67 60 54    0 
17 59 41 48 49   70 48 60 55 54 70 49 55 60   0 
18 62 71 68 62 62 67 110 78 111 92 92 78 89 82 77 78 84 0 
19 69 66 55    76 79 69 65 82 84 81 72    0 
20 51 53 53 62 53 56 86 88 67 63 65 63 66 65 75 67 72 0 
21 47 63 61 58 59  90 73 63 56 65 61 63 61 58 59  0 
22 43 59 79 57 50 43 93 81 66 97 101 57 82 83 75 66 56 0 
23 70 61 50 90 67  61 60 82 80 83 89 74 59 100 80  0 
24 55 54 64    81 103 58 52 57 55 63 70    0 
25 54 58 63    80 76 64 63 82 72 72 76    0 
26 
 
                 
107 
 
27 44 49 49 49 52  68 71 63 62 57 55 63 63 61 65  0 
28 49 44 46 64 66  92 71 46 44 82 65 56 57 75 78  0 
29 56 44 61 62   79 46 51 69 76 59 84 84    0 
30 61 57 59 61   101 67 59 56 73 72 68 71 72   0 
31 49 55 47 45 45  82 76 61 60 57 58 68 59 55 57  0 
32 72 50 62 60   116 69 69 77 89 88 60 75 73   0 
33 60 52 49 41 43 39 73 73 47 55 62 64 64 63 56 58 60 0 
34 52 50 50 49 51 51 71 65 77 89 66 64 61 59 60 61 62 0 
35 65 51 48 45   89 51 44 47 74 82 65 62 60   0 
36 61 56 64    95 87 61 66 75 65 66 80    0 
37 52 80 64    105 105 109 102 94 66 91 74    0 
38 
 
                 
39 59 59 54 64   100 84 49 64 59 72 72 70 68   0 
40 80 66 59 70 80 61 97 92 61 61 79 107 83 75 93 95 81 0 
41 66 60 67 56   86 81 68 70 67 80 72 82 70   0 
42 68 58 69    83 80 74 78 73 80 76 93    0 
43 64 75 52 61   94 85 63 86 82 77 96 65 81   0 
44 54 55 53 89   108 110 51 50 60 67 70 66 113   0 
45 68 58 70 51 45  69 71 70 73 99 90 76 92 67 62  0 
46 64 61 73    85 98 62 62 69 86 78 87    0 
47 57 46 54    96 74 73 86 82 68 56 66    0 
48 53 45 47 49   76 82 70 70 67 70 61 73 66   0 
49 47 44 49 49   80 78 52 58 79 62 57 64 63   0 
50 37 41 51 55   78 61 66 62 63 53 55 60 78   0 
51 92 62 84 57 55  91 67 71 50 70 106 73 95 65 65  0 
52 66 72 60 42 45 43 84 87 100 100 90 86 70 76 54 58 57 0 
53 41 40 39 49   89 83 73 83 64 54 54 55 67   0 
54 55 61 64 57 50  94 84 64 63 68 65 73 75 66 65  0 
55 53 44 58 56   92 81 69 64 68 67 55 72 71   0 
56 39 58 50 53   86 55 77 88 62 50 76 66 70   0 
57 66 69 51 47   94 83 80 88 81 81 87 63 57   0 
58 64 47 52 58   87 53 53 60 66 80 58 66 72   0 
59 52 49 50    95 85 77 76 63 62 60 60    0 
60 63 57 49 55   93 64 64 82 83 63 75 62 72   0 
61 77 64 65 44   108 102 74 71 86 100 79 81 56   0 
62 63 60 61    84 85 45 75 77 77 73 75    0 
63 56 75 63 73 59 57 83 82 74 76 70 66 92 78 85 73 70 0 
64 61 56 64    95 87 61 66 75 65 66 80    0 
65 50 57 47 45   79 64 87 82 76 72 85 65 62   0 
66 45 49 65    103 62 52 69 55 60 66 87    0 
67 56 67 59 62   99 97 112 78 89 73 93 75 85   0 
68 66 59 62 58   88 57 69 72 68 82 73 77 72   0 
69 59 61     101 74 71 56 74 72 74     0 
70 48 59 63 54   81 81 65 65 62 60 73 66 65   0 
71 47 53 48 51 47  90 139 69 58 64 60 66 58 65 59  0 
108 
 
72 65 44 55 54   96 92 57 58 64 75 54 55 64   0 
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1 0.9 0.8 0.8 0.8 0.7 0.7 0.8 0.7   0 0.8 0.7 0.7 0.7 
2 0.9 0.75 0.7 0.75 0.7 0.75 0.7    0 0.8 0.6 0.6 0.6 
3 1.2 0.9 0.9 0.7 1.2 1 0.9    0 1 0.7 0.8 0.6 
4 1 1.2 1 0.7 0.75 0.75 0.75 0.8   0 1 1 0.9 0.6 
5 1 1.3 0.85 0.85 0.85 0.95 0.85 0.8   0  0.7 0.7 0.7 
6 0.9 1.1 1.05 0.85 0.95 0.9 0.9 1   0 0.6 1.1 0.9 0.8 
7 1.6 0.7 0.85 0.95 0.85 0.75 0.75 0.7   0 1.4 0.7 0.7 0.8 
8 1.1 0.6 0.5 0.5 0.5 0.7 0.8    0 1.1 0.5 0.5 0.4 
9 1 0.55 0.55 0.6 0.9 0.65 0.9 0.75   0 1 0.4 0.4 0.5 
10 0.9 0.8 0.8 0.85 0.8 0.65 0.7 0.65   0 0.8 0.7 0.7 0.7 
11 1.1 1.3 1.2 0.8 0.75 0.9 0.9 0.95   0 1 1.1 1 0.7 
12 0.8 0.85 0.8 0.8 0.85 0.65 0.6 0.7 0.7 0.85 0 0.7 0.7 0.7 0.7 
13 0.6 0.65 0.6 0.7 0.8 0.7 0.65 0.65 0.7  0 0.5 0.5 0.6 0.7 
14 0.9 0.7 0.8 1 1.1 1 0.9 1 1  0 0.8 0.6 0.7 0.9 
15 1 0.8 0.6 0.6 0.6 0.6 0.7    0 0.9 0.7 0.5 0.5 
16 1.05 1 0.8 0.85 0.75 0.7 0.95    0 0.9 0.9 0.7 0.7 
17 0.8 0.95 0.45 0.35 0.6 0.45 0.55 0.7   0 0.7 0.8 0.3 0.3 
18 1.3 1.2 1.15 1.05 0.9 0.85 1.05 1.05 1 0.9 0 0.8 1 1 0.9 
19 1.05 0.75 0.65 0.65 0.65 0.7 0.65    0 0.9 0.6 0.6 0.6 
20 1.9 1 1.05 0.85 0.85 0.75 0.95 1.05 0.9 0.95 0 1.5 0.9 0.9 0.8 
21 0.9 0.65 0.7 0.6 0.6 0.65 0.9 1 1  0 0.8 0.5 0.6 0.5 
22 1 0.3 0.2 0.4 0.5 0.55 0.7 0.6 0.6 0.6 0 0.9 0.2 0.2 0.3 
23 0.75 0.7 0.75 0.75 0.8 0.65 0.6 0.7 
0.7
5  0 0.6 0.6 0.6 0.6 
24 0.9 0.95 0.95 0.95 0.6 0.75 0.7    0 0.8 0.8 0.8 0.6 
25 0.8 1 0.9 1 1 1.2 0.7    0 0.6 0.6 0.6 0.8 
26 
  
             
27 1.1 1.15 1.2 1.2 1.2 0.9 0.9 1 
0.9
5  0 1 1 1 1.1 
28 0.95 0.95 0.95 0.9 0.9 0.8 1 1.1 1.2  0 0.8 0.9 0.8 0.8 
29 1.3 1.4 0.7 0.6 0.5 0.8 0.6 0.8   0 1.2 1.2 0.8 0.8 
30 0.9 0.5 0.4 0.45 0.55 0.55 0.6 0.6   0 0.8 0.4 0.3 0.3 
31 1 0.9 0.8 0.75 0.75 0.7 0.75 0.85 
0.8
5  0 0.9 0.8 0.7 0.6 
32 0.85 0.75 0.75 0.7 0.7 0.75 0.7 0.7   0 0.7 0.6 0.6 0.6 
33 0.5 0.75 0.85 0.9 0.9 0.8 0.75 0.9 0.8 0.6 0 0.4 0.6 0.7 0.8 
34 0.5 0.6 0.6 0.7 0.7 1 1 0.9 1 1 0 0.4 0.5 0.5 0.6 
35 1.2 1.1 1 0.7 0.75 0.75 0.75 0.8   0 1 1 0.9 0.6 
36 1.1 0.95 1 1 1 0.9 1.1    0 1 0.8 0.9 1 
37 0.8 0.9 0.6 0.65 0.75 0.85 0.65    0 0.7 0.8 0.6 0.6 
109 
 
38 
  
             
39 1 0.9 1 0.8 0.9 0.6 0.6 0.7   0 0.9 0.8 0.7 0.7 
40 0.95 0.8 0.85 0.85 0.65 0.8 0.8 0.65 0.8 0.9 0 0.8 0.7 0.7 0.7 
41 1 0.9 0.9 0.7 0.8 0.8 0.8 0.8   0 0.9 0.8 0.8 0.6 
42 1.1 1 0.9 0.7 0.7 0.9 0.8    0 1 0.9 0.8 0.6 
43 0.9 1.1 1.1 1.1 0.95 0.8 0.8 0.75   0 0.8 1 1 1 
44 0.5 0.75 0.95 0.8 0.9 0.9 1.05 0.3   0 0.4 0.6 0.8 0.7 
45 1 0.85 1 1 1.2 1.15 1 1.2 0.9  0 0.9 0.7 0.9 0.9 
46 0.8 0.75 0.85 0.35 0.35 0.65 0.3    0 0.7 0.6 0.7 0.2 
47 0.7 0.8 0.8 0.95 0.9 0.8 0.8    0 0.8 0.8 0.9 0.9 
48 0.5 1.15 1.05 0.85 0.8 0.8 0.75 0.65   0 0.4 0.9 0.9 0.7 
49 1 1 0.6 0.5 0.75 0.7 0.95 1.1   0 0.9 0.9 0.5 0.4 
50 1.2 1.1 1 0.7 0.85 0.7 0.6 0.7   0 1.1 0.9 0.8 0.7 
51 1 1.2 1.3 1 0.8 0.9 1.05 0.7 
0.7
5  0 0.9 1 1.1 0.9 
52 0.7 1.2 1.2 0.8 0.7 1 0.9 1 1 1.5 0 0.6 1 1 0.7 
53 0.7 0.65 0.6 0.65 0.75 0.7 0.75 0.8   0 0.6 0.5 0.5 0.5 
54 1.05 0.9 0.95 0.9 0.8 0.95 0.9 0.8 
0.7
5  0 0.9 0.8 0.8 0.8 
55 1 0.9 0.85 0.75 0.9 1.05 1.2 1.3   0 0.9 0.8 0.7 0.6 
56 0.9 0.7 0.6 0.8 0.95 0.95 0.9 1.1   0 0.8 0.6 0.5 0.7 
57 0.9 0.9 0.9 0.7 0.65 0.7 0.75 0.7   0 0.8 0.8 0.8 0.6 
58 0.6 1.3 1.2 0.8 0.75 0.9 0.9 0.95   0 0.5 1.1 1 0.7 
59 0.8 0.7 0.75 0.75 0.75 0.9 0.7    0 0.7 0.6 0.6 0.6 
60 1 1.3 1.1 0.75 0.6 0.65 0.7 0.65   0 0.9 1.1 0.9 0.6 
61 1 1.1 1 0.85 0.7 0.8 0.85 0.85   0 0.9 0.9 0.9 0.7 
62 0.9 0.8 0.75 0.75 0.75 0.75 0.75    0 0.8 0.7 0.6 0.6 
63 1 1.1 0.9 0.7 0.8 0.8 0.8 0.8 0.9 1 0 0.9 0.9 0.8 0.6 
64 0.7 0.95 1 1 1 0.9 1.1    0 0.6 0.8 0.9 0.9 
65 1 1.4 1.35 1 1.05 1.35 1.2 1.15   0 0.9 1.2 1.1 0.9 
66 1.1 1.2 1.15 1 1 1.15 0.8    0 0.9 1 1 0.9 
67 0.5 0.7 0.9 0.75 0.7 1.1 0.8 1   0 0.4 0.6 0.8 0.6 
68 1.05 0.95 0.9 0.7 0.65 0.8 0.75 0.7   0 0.9 0.8 0.8 0.6 
69 1 1.15 0.9 0.8 0.75 0.6     0 0.9 0.9 0.8 0.7 
70 0.6 0.65 0.65 0.7 0.7 0.6 0.65 0.65   0 0.5 0.5 0.5 0.6 
71 1 1.2 0.9 0.8 0.8 0.75 0.8 0.7 
0.8
5  0 0.9 1 0.8 0.7 
72 1 0.9 0.8 0.7 0.7 0.6 0.7 0.6   0 0.9 0.8 0.7 0.6 
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1 0.6 0.6 0.7 0.6   100 55 56 56 61 55 48 52 44  
2 0.6 0.6 0.6    100 34 42 42 45 56 48    
3 1.1 0.9 0.8    99 76 34 38 48 42 38 44   
110 
 
4 0.6 0.6 0.6 0.7   95 86 39 44 54 51 54 45 49  
5 0.7 0.8 0.7 0.7   87 43 32 32 48 47 44 47 53  
6 0.8 0.8 0.9 1   97 62 33 31 47 56 56 46 42  
7 0.7 0.6 0.6 0.6   97 88 38 39 44 48 42 44 52  
8 0.4 0.6 0.7    98 82 50 48 49 34 38 42   
9 0.8 0.5 0.8 0.6   96 82 44 40 36 52 42 58 49  
10 0.6 0.5 0.6 0.5   99 82 34 38 48 52 52 48 46  
11 0.7 0.8 0.8 0.8   99 80 39 31 51 57 49 52 53  
12 0.8 0.5 0.5 0.5 0.6 0.7 94 70 44 42 46 46 48 49 48 44 
13 0.7 0.6 0.5 0.5 0.6  93 26 44 45 42 45 40 42 40 62 
14 1 0.9 0.8 0.9 0.9  98 98 53 55 36 41 33 39 35 33 
15 0.5 0.5 0.6    84 73 32 32 44 40 35 54   
16 0.6 0.6 0.8    84 76 56 48 52 44 55 47   
17 0.5 0.3 0.4 0.6   74 30 37 37 65 42 37 44 52  
18 0.8 0.7 0.9 0.9 0.9 0.8 95 45 32 36 38 41 41 38 48 43 
19 0.6 0.6 0.6    96 96 47 48 39 41 43 50   
20 0.7 0.7 0.85 0.9 0.8 0.8 97 88 49 41 41 42 41 42 39 46 
21 0.5 0.6 0.8 0.9 0.9  94 84 61 60 59 44 56 53 54 30 
22 0.4 0.5 0.6 0.5 0.5 0.5 97 77 43 45 48 44 46 42 40 41 
23 0.7 0.6 0.5 0.6 0.7  97 50 34 32 41 40 39 40 41 40 
24 0.6 0.6 0.6    97 92 43 39 32 41 54 59   
25 0.8 0.8 0.7    90 70 58 57 58 49 44 46   
26 
 
               
27 1.1 0.8 0.8 0.9 0.8  97 42 34 30 25 24 40 40 33 43 
28 0.8 0.7 0.9 1 1  97 57 52 53 54 52 50 43 42 42 
29 0.6 0.5 0.4 0.7   96 48 37 48 57 53 51 59 53  
30 0.4 0.4 0.5 0.5   97 54 54 34 48 39 22 44 39  
31 0.6 0.6 0.6 0.7 0.7  90 80 60 60 56 59 61 58 59 59 
32 0.6 0.6 0.6 0.6   99 60 40 35 35 35 44 42 49  
33 0.8 0.7 0.6 0.8 0.7 0.5 98 70 60 50 47 45 47 40 49 55 
34 0.6 0.9 0.9 0.8 0.9 0.9 94 88 56 60 60 49 42 47 49 50 
35 0.6 0.6 0.6 0.7   95 90 39 44 54 51 54 45 49  
36 0.8 0.8 0.9    99 32 40 42 50 56 52 42   
37 0.7 0.8 0.5    98 97 48 47 44 42 40 36   
38 
 
               
39 0.8 0.5 0.5 0.6   95 89 69 65 60 61 60 63 50  
40 0.5 0.7 0.7 0.5 0.7 0.8 94 66 41 40 39 42 37 42 41 39 
41 0.7 0.7 0.7 0.7   98 43 36 28 38 45 42 44 46  
42 0.6 0.8 0.7    94 57 38 42 48 42 48 52   
43 0.8 0.7 0.7 0.6   99 35 36 48 42 42 52 48 48  
44 0.8 0.8 0.9 0.2   98 96 39 44 48 40 41 42 95  
45 1 1 0.9 0.9 0.8  95 92 32 42 56 52 42 44 50 60 
46 0.2 0.5 0.2    98 88 37 29 35 28 48 43   
47 0.9 0.7 0.7    96 53 57 52 49 54 54 59   
48 0.7 0.7 0.6 0.5   98 30 32 32 34 38 34 38 48  
111 
 
49 0.6 0.6 0.8 0.9   98 66 39 43 47 46 48 44 37  
50 0.8 0.6 0.5 0.6   90 45 42 30 33 36 42 44 58  
51 0.7 0.8 0.9 0.6 0.6  89 44 45 35 34 42 41 32 44 40 
52 0.9 0.8 0.8 0.9 0.9 1 98 93 40 30 50 62 55 56 63 62 
53 0.6 0.6 0.6 0.7   97 46 45 47 47 44 47 48 45  
54 0.75 0.8 0.8 0.7 0.7  90 45 43 39 39 42 43 38 54 58 
55 0.8 0.9 1 1   98 42 63 64 65 61 63 62 58  
56 0.8 0.8 0.8 1   96 77 37 43 48 41 38 46 48  
57 0.5 0.6 0.6 0.6   93 67 42 43 48 50 42 40 38  
58 0.6 0.8 0.8 0.8   89 46 39 31 51 57 51 52 53  
59 0.6 0.8 0.6    85 88 36 38 37 37 38 42   
60 0.5 0.5 0.6 0.5   95 46 33 30 40 53 58 48 45  
61 0.6 0.7 0.7 0.7   98 78 35 38 52 48 47 51 56  
62 0.6 0.6 0.6    97 90 35 38 55 24 25 23   
63 0.7 0.7 0.7 0.7 0.8 0.9 97 69 45 42 42 45 49 58 53 58 
64 0.9 0.8 0.9    96 79 52 48 42 41 50 47   
65 0.9 1.1 1.1 1   99 89 46 46 49 47 56 46 45  
66 0.9 1 0.7    96 89 53 53 48 47 41 65   
67 0.6 1 0.7 0.9   95 86 57 57 52 61 49 47 42  
68 0.5 0.7 0.6 0.6   98 92 43 37 43 45 44 41 44  
69 0.6 0.5     97 88 38 39 42 47 48    
70 0.6 0.5 0.5 0.5   99 90 53 47 45 41 39 39 41  
71 0.7 0.6 0.7 0.6 0.7  95 80 35 42 46 46 48 48 46 52 
72 0.6 0.5 0.6 0.5   93 77 40 44 49 48 55 45 51  
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1 
 
10 2 2 2 0 0 2 0 100 3.5 
2 
 
12 2 10 5 5 0 2 0 100 2 
3 
 
11 2 1 1 0 1 2 2 300 2.5 
4 
 
7 2.3 2 2 0 0 2 0 200 3.5 
5 
 
7 2 2 2 0 0 2 0 400 3.2 
6 
 
4.5 2 0 0 0 0 0 0 300 3.7 
7 
 
8 2 1 1 0 0 0 0 200 3.5 
8 
 
7 4 0 0 0 2 3 0 200 2.7 
9 
 
8 2.4 4 2 2 0 2 0 400 3.3 
10 
 
2 3 6 1 5 0 2 0 200 3.5 
11 
 
5 2.5 2 2 0 0 2 0 300 3.2 
12 43 10 4 0 0 0 1 3 0 800 5 
13 
 
15 4 4 4 0 6 4 0 400 3.5 
14 
 
5 2 4 0 4 0 2 0 500 5 
15 
 
5 2 0 0 0 0 2 0 250 2.8 
16 
 
20 2 13 0 13 0 2 0 250 2.5 
112 
 
17 
 
10 2 5 5 0 1 2.2 0 300 3 
18 43 9.5 4 0 0 0 0 2 0 800 5 
19 
 
6 2 0 0 0 1 2 0 50 2 
20 43 13 3 5 0 0 0 2 0 400 5 
21 
 
10 2 7 6 1 0 2 0 150 4 
22 42 9 4 15 5 10 0 2.5 0 800 6 
23 
 
9 5 5 2 4 1 2 0 400 4 
24 
 
17 2 3 3 0 0 2 0 200 2.5 
25 
 
7 2 0 0 0 0 2 0 50 2.5 
26 
  
         
27 
 
15 3 2 2 0 0 3 0 750 4.5 
28 
 
2 2 3 3 0 0 2 0 600 4 
29 
 
20 2.3 5 5 0 2 2.5 0 150 3.5 
30 
 
11 5 0 0 0 5 6 0 500 3.5 
31 
 
11 2 11 6 5 0 1 0 500 4 
32 
 
13 3 2 2 0 0 1 0 300 2.5 
33 62 20 3 7 7 0 3 2 1 800 5.5 
34 54 21 4 9 0 9 0 2 0 350 5.5 
35 
 
5 3 2 2 0 0 3 0 200 4 
36 
 
13 2.5 1 1 0 1 2 1 100 3 
37 
 
10 2 1 1 0 0 2 0 200 3 
38 
  
         
39 
 
5 3 5 4 1 0 4 0 200 4 
40 47 14 4 2 2 0 3 4 0 200 5.5 
41 
 
10 3 1 1 0 0 2 0 400 3.5 
42 
 
5 2 0 0 0 0 2 0 50 2 
43 
 
10 2 2 2 0 1 2 0 400 3.5 
44 
 
10 3 4 4 0 0 3 0 400 3 
45 
 
15 5 0 0 0 5 4 0 900 5 
46 
 
7 3 3 3 0 4 4 1 300 3 
47 
 
5 3 15 5 10 0 2 0 200 3 
48 
 
5 2 0 0 0 0 2 0 250 3 
49 
 
3 4 6 6 0 0 3 0 200 3.5 
50 
 
10 3 5 5 0 1 2 0 150 3 
51 
 
7 4 5 5 0 0 2 0 200 3 
52 55 7 4 17 0 17 3 2 0 900 6 
53 
 
7 4 5 5 0 0 2 0 200 3 
54 
 
8 2 2 2 0 0 2 0 500 4 
55 
 
5 4 0 0 0 0 3 1 300 3 
56 
 
5 3 4 4 0 0 3 0 350 3.5 
57 
 
11 3 0 0 0 2 3 1 300 3 
58 
 
8 2 2 2 0 0 2 0 300 3.5 
59 
 
5 2 1 1 0 0 2 0 250 2 
60 
 
6 2 5 5 0 0 4 0 300 3 
61 
 
10 5 2 2 0 2 4 0 200 3 
113 
 
62 
 
15 2 5 5 0 0 2 0 300 3 
63 42 10 6 6 6 0 0 5 0 1500 6 
64 
 
13 3 2 2 0 0 2 0 200 3 
65 
 
5 4 1 1 0 0 2 0 200 4 
66 
 
6 3 5 5 0 0 2 0 200 2 
67 
 
20 4 0 0 0 5 4 0 500 4.5 
68 
 
5 4 0 0 0 0 3 0 200 3 
69 
 
3 4 3 3 0 0 2 0 50 2 
70 
 
10 3 1 1 0 0 2 0 400 3.2 
71 
 
5 4 9 9 0 0 2 0 400 4.5 
72 
 
6 3 0 0 0 0 2 0 300 3 
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